Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
<< vorige    volgende >>
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             2253 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1001 Genetic analysis of Koreans with early-onset Alzheimer's disease, updated Bagyinszky, Eva
2013
9 4S p. P177-P178
artikel
1002 Genetic analysis of PGRN and MAPT genes in Koreans with diverse neurodegenerative disorders Bagyinszky, Eva
2013
9 4S p. P558
artikel
1003 Genetic and brain atrophy markers associated with different psychological phenotypes within ADNI Woodward, Felix
2013
9 4S p. P525
artikel
1004 Genetic and imaging biomarkers predicting beta-amyloid amyloid–related cognitive decline using the Alzheimer's Disease Neuroimaging Initiative data Feng, Sheng
2013
9 4S p. P178
artikel
1005 Genetic determinants of progression of Alzheimer's disease Wang, Xingbin
2013
9 4S p. P554
artikel
1006 Genetic interaction analysis of Alzheimer's disease progression using phospho-tau as a covariate Sun, Ying
2013
9 4S p. P555-P556
artikel
1007 Genetic modifiers in early-onset familial Alzheimer’s disease in Caribbean Hispanics Lee, Joseph
2013
9 4S p. P692
artikel
1008 Genetic modifiers of cognitive maintenance Yokoyama, Jennifer
2013
9 4S p. P558
artikel
1009 Genetic resilience to amyloid-related neurodegeneration in older adulthood Hohman, Timothy
2013
9 4S p. P258
artikel
1010 Genetic screening for mild cognitive impairment in people with cardiovascular risk factors Yaneva-Sirakova, Teodora
2013
9 4S p. P770-P771
artikel
1011 Genetic variants associated with incidence of late-onset Alzheimer's disease in Caucasians Choi, Seung Hoan
2013
9 4S p. P176
artikel
1012 Genetic variation in PLXNA4 associated with susceptibility of Alzheimer’s disease through tau phosphorylation Jun, Gyungah
2013
9 4S p. P692
artikel
1013 Gene-wide and pathway analyses identify new susceptibility genes and pathways related to Alzheimer's disease Moskvina, Valentina
2013
9 4S p. P123
artikel
1014 Genome-wide analysis of DNA methylation differentiates late-onset Alzheimer's disease from dementia with Lewy bodies Humphries, Crystal
2013
9 4S p. P171-P172
artikel
1015 Genome-wide analysis of genetic variants associated with depressive symptoms in older adults Nho, Kwangsik
2013
9 4S p. P552-P553
artikel
1016 Genome-wide association analyses of onset age in late-onset Alzheimer disease (LOAD) demonstrate no strong effect outside of the APOE region Naj, Adam
2013
9 4S p. P554
artikel
1017 Genome-wide association study and admixture mapping of age-related cognitive decline in African-Americans Raj, Towfique
2013
9 4S p. P678-P679
artikel
1018 Genome-wide association study for cognitive decline Chibnik, Lori
2013
9 4S p. P559-P560
artikel
1019 Genome-wide association study identifies susceptibility loci associated with the rate of cognitive decline Chung, Jaeyoon
2013
9 4S p. P560-P561
artikel
1020 Genome-wide SNP analysis finds executive-prominent late-onset Alzheimer's disease is highly heritable Trittschuh, Emily
2013
9 4S p. P550-P551
artikel
1021 Genotype patterns for APOE, PICALM and CLU influence episodic memory Ferencz, Beata
2013
9 4S p. P792
artikel
1022 Genotype-phenotype studies examining the CD33 locus and amyloid biology Bradshaw, Elizabeth
2013
9 4S p. P692-P693
artikel
1023 Geographical variation in dementia prevalence in Swedish twins: Using Bayesian inference to separate genetic and environmental effects Russ, Tom
2013
9 4S p. P688-P689
artikel
1024 GEPT extract prevents beta-amyloid-deposition–induced synaptic dysfunction in APPV717I transgenic mice, possibly by adjusting the expression of CaMKII and CaN Shi, Jing
2013
9 4S p. P501
artikel
1025 Glia impairment and Alzheimer's disease: New insights for the development of Alzheimer's disease pathology Lifshitz, Veronica
2013
9 4S p. P193
artikel
1026 Glucose metabolism in Alzheimer's disease: It's not just about energy Raichle, Marc
2013
9 4S p. P825
artikel
1027 Glutamate dysregulation in tau P301L mice Hunsberger, Holly
2013
9 4S p. P714
artikel
1028 γ-glutamylcysteine (GGC)-mediated upregulation of glutathione levels can ameliorate toxicity of natural beta-amyloid oligomers in primary adult human neurons Braidy, Nady
2013
9 4S p. P854
artikel
1029 Going new ways in dementia care with DelpHi-MV: An innovative concept of collaborative dementia care management in Germany Eichler, Tilly
2013
9 4S p. P491
artikel
1030 G-protein signalling associated with membrane APP-CTF accumulation Parent, Angele
2013
9 4S p. P531
artikel
1031 Granulocyte colony stimulating factor (GCSF) alone and in combination with memantine improves not only memory but also co-morbid associated depression in a beta-amyloid-induced experimental model of Alzheimer's disease Prakash, Ajay
2013
9 4S p. P499
artikel
1032 Gray matter correlates of Alzheimer's disease risk as quantified with latent information in semantic fluency lists Clark, David
2013
9 4S p. P450
artikel
1033 Gray matter correlates of Alzheimer's disease risk as quantified with latent information in semantic fluency lists Clark, David
2013
9 4S p. P74
artikel
1034 Gray matter correlates of interlocking pentagon drawing in Alzheimer's disease Yang, Dong Won
2013
9 4S p. P742
artikel
1035 Grey matter graph properties are related to disease severity in Alzheimer's disease Tijms, Betty
2013
9 4S p. P259
artikel
1036 GWAS of rate of cognitive decline in four populations Sherva, Richard
2013
9 4S p. P707
artikel
1037 GWAS of the joint ADGC data set identifies novel common variants associated with late-onset Alzheimer's disease Mukherjee, Shubhabrata
2013
9 4S p. P550
artikel
1038 Haplotypes at the MAPT locus associate with risk for LOAD and brain gene expression Allen, Mariet
2013
9 4S p. P829
artikel
1039 Harvard College Alzheimer's Buddies Program: Extending the intergenerational model Christ, Ryan
2013
9 4S p. P649
artikel
1040 Head trauma and risk of dementia in the oldest-old: The Monzino 80-plus study Lucca, Ugo
2013
9 4S p. P614
artikel
1041 Healing gardens in Alzheimer's disease: How to best leverage skills and experience between health and landscape professionals—The Nancy experience Jonveaux, Therese Rivasseau
2013
9 4S p. P489
artikel
1042 Healthy aging affects cholinergic functional networks Grothe, Michel
2013
9 4S p. P394-P395
artikel
1043 Healthy aging affects cholinergic functional networks Grothe, Michel
2013
9 4S p. P107-P108
artikel
1044 Heart rate variability in Alzheimer's disease and mild cognitive impairment Kim, Hyun
2013
9 4S p. P211-P212
artikel
1045 Hepatitis B, Down syndrome and Alzheimer's disease: A role for cytokines? Lai, Florence
2013
9 4S p. P865
artikel
1046 HHEX_23 AA genotype exacerbates the risk effect of diabetes on Alzheimer's disease Xu, Weili
2013
9 4S p. P625
artikel
1047 Hierarchical structure of the activities of daily living scale in dementia Delva, Fleur
2013
9 4S p. P746-P747
artikel
1048 HIF-1α and notch signaling regulate cell viabilities through an interactional way in the coculture system of mouse hippocampal neurons and astrocytes Zheng, Jin
2013
9 4S p. P354-P355
artikel
1049 High neuroticism in caregivers is associated with greater burden independent of degree of cognitive impairment or neuropsychiatric symptoms Sink, Kaycee
2013
9 4S p. P493
artikel
1050 High-performing older adults: Cognitive and brain correlates Wirth, Miranka
2013
9 4S p. P134
artikel
1051 High-resolution, graph-based analysis reveals pervasive functional disconnection in mild cognitive impairment Minati, Ludovico
2013
9 4S p. P268
artikel
1052 High-resolution imaging of medial temporal lobe subfield structure and function in mild cognitive impairment Carr, Valerie
2013
9 4S p. P111
artikel
1053 High-resolution imaging of medial temporal lobe subfield structure and function in mild cognitive impairment Carr, Valerie
2013
9 4S p. P337-P338
artikel
1054 High use of dietary supplements is associated with a decreased risk of cognitive impairment: A cohort study from KLOSCAD So, Yoonseop
2013
9 4S p. P803
artikel
1055 High use of opioids in people with dementia Jensen-Dahm, Christina
2013
9 4S p. P292
artikel
1056 Hilar transplantation of MGE-derived inhibitory interneuron progenitors restores normal learning and memory in Alzheimer's disease mouse models Tong, Leslie
2013
9 4S p. P856
artikel
1057 Hippocampal deformity in nonsemantic primary progressive aphasia Christensen, Adam
2013
9 4S p. P375-P376
artikel
1058 Hippocampal deformity in nonsemantic primary progressive aphasia Christensen, Adam
2013
9 4S p. P42
artikel
1059 Hippocampal sclerosis of aging, a key potential Alzheimer’s disease confounder: The NACC experience Brenowitz, Willa
2013
9 4S p. P542
artikel
1060 Hippocampal subfield atrophy in preclinical and predementia Alzheimer's disease is different from atrophy observed in non-Alzheimer’s pathology Hanseeuw, Bernard
2013
9 4S p. P93
artikel
1061 Hippocampal subfields and stress in nondemented older adults: Preliminary findings Zimmerman, Molly
2013
9 4S p. P395-P396
artikel
1062 Hippocampal subfields segmentation using automated method in people with Alzheimer's disease Won, Wangyoun
2013
9 4S p. P424
artikel
1063 Hippocampal texture predicts conversion from MCI to Alzheimer’s disease Sørensen, Lauge
2013
9 4S p. P52
artikel
1064 Hippocampal texture predicts conversion from MCI to Alzheimer's disease Sørensen, Lauge
2013
9 4S p. P581
artikel
1065 Hippocampal transcriptome-guided gene-gene interaction of memory phenotype in MCI and Alzheimer’s disease Yan, Jingwen
2013
9 4S p. P4
artikel
1066 Hippocampal transcriptome-guided gene-gene interaction of memory phenotype in MCI and Alzheimer's disease Yan, Jingwen
2013
9 4S p. P224-P225
artikel
1067 Histamine H3 antagonists in Alzheimer's disease: Exploring the translational disconnect between rodent models and humans Geerts, Hugo
2013
9 4S p. P663
artikel
1068 Homocysteine accelerates tau aggregation via caspase activation Shirafuji, Norimichi
2013
9 4S p. P715
artikel
1069 Homozygous TREM2 mutations: Another addition to the list of genetic causes of familial frontotemporal dementia Gurvit, Hakan
2013
9 4S p. P860
artikel
1070 Hospitalized Alzheimer's disease or dementia in Canada Dai, Sulan
2013
9 4S p. P689
artikel
1071 Household members of people with Alzheimer's disease: Health conditions, health care resource utilization and health care costs Shah, Sonali
2013
9 4S p. P482
artikel
1072 How aerobic exercise affects cognition: A pilot study Yu, Fang
2013
9 4S p. P478-P479
artikel
1073 How does dementia severity affect the costs of dementia care? Rattinger, Gail
2013
9 4S p. P344-P345
artikel
1074 How do we define amyloid positivity in an asymptomatic population? Comparison of CSF, quantitative PET and clinical PET examinations Rubin, Brian
2013
9 4S p. P6
artikel
1075 How safe is combination memantine/donepezil treatment in people with Alzheimer's disease? Safety evaluations based on 23 clinical studies Mayer, Monika
2013
9 4S p. P282
artikel
1076 5-HT4 receptor occupancy assay in mice striatum using LC-MS/MS-based tracer analysis Nirogi, Ramakrishna
2013
9 4S p. P165
artikel
1077 Human iPSC-derived neurons reveal novel effects of the APP London mutation and show cell fate-specific Alzheimer’s disease relevant phenotypes Muratore, Christina
2013
9 4S p. P126-P127
artikel
1078 Human stem cell models of frontotemporal dementia caused by a non-coding hexanucleotide repeat expansion in C9ORF72 Wray, Selina
2013
9 4S p. P127
artikel
1079 25-Hydroxyvitamin D, cognition and Alzheimer's disease Roullet, Florence
2013
9 4S p. P244
artikel
1080 Hyperhomocysteinemia exacerbates cerebral amyloid angiopathy and cognitive decline through the beta-amyloid and fibrinogen interaction in Alzheimer's disease Chung, Young Cheul
2013
9 4S p. P856-P857
artikel
1081 Hyperhomocysteinemia impairs synaptic plasticity and promotes neural cell proliferation Jiang, Xia
2013
9 4S p. P711
artikel
1082 Hypertension, cognitive function and ventricular volume in people with CADASIL Lee, Jung Seok
2013
9 4S p. P587
artikel
1083 Hypometabolism in PiB-positive, population-based, cognitively normal subjects with and without APOE-ɛ4 Lowe, Val
2013
9 4S p. P59
artikel
1084 Hypometabolism in PiB-positive, population-based, cognitively normal subjects with and without APOE-ε4 Weigand, Stephen
2013
9 4S p. P317
artikel
1085 Hypothyroidism in the elderly Martinelli, Jose
2013
9 4S p. P878
artikel
1086 Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer's disease using metabolomics Trushina, Eugenia
2013
9 4S p. P243
artikel
1087 Identification of an alternative APP processing pathway Willem, Michael
2013
9 4S p. P181
artikel
1088 Identification of an important potential confound in CSF Alzheimer's disease studies: Aliquot volume Paterson, Ross
2013
9 4S p. P215-P216
artikel
1089 Identification of a novel MAPT variation in intron 9 in an individual with frontotemporal lobar degeneration Rönnbäck, Annica
2013
9 4S p. P557-P558
artikel
1090 Identification of misdiagnosed frontotemporal dementia using apolioprotein genotype and linear discriminant analysis Hernandez, Isabel
2013
9 4S p. P754
artikel
1091 Identification of variants that confer susceptibility to Alzheimer's disease in the Amish through exome sequencing D'Aoust, Laura
2013
9 4S p. P175
artikel
1092 Identifying multi-analyte CSF biomarkers for Alzheimer’s disease in a multi-cohort study Leung, Yuk Yee
2013
9 4S p. P128-P129
artikel
1093 Identifying novel CSF markers of brain atrophy in Alzheimer's disease and mild cognitive impairment using a multiplex panel of analytes Kiddle, Steven
2013
9 4S p. P227
artikel
1094 Identifying prodromal Alzheimer's disease in an MCI cohort using EEG Jóhannesson, Gísli
2013
9 4S p. P370-P371
artikel
1095 Idiopathic normal-pressure hydrocephalus, Alzheimer's disease and cortical thinning Kang, Kyunghun
2013
9 4S p. P872
artikel
1096 IL7 and depression: The importance of gender and blood fraction Hall, James
2013
9 4S p. P235-P236
artikel
1097 Image-derived arterial input function for PiB quantification Su, Yi
2013
9 4S p. P21
artikel
1098 Image interpretation method of [C-11]BF-227 amyloid PET in J-ADNI Okamura, Nobuyuki
2013
9 4S p. P383
artikel
1099 Imaging and cerebrospinal fluid (CSF) biomarkers for differentiating dementia with Lewy bodies (DLB) from Alzheimer's disease (AD): A meta-analysis of test performance Nihashi, Takashi
2013
9 4S p. P368-P369
artikel
1100 Imaging genetics of SPON1 gene variant rs11023139 in Alzheimer's disease Nho, Kwangsik
2013
9 4S p. P84
artikel
1101 Imaging genetics of the SPON1 gene variant rs11023139 in Alzheimer's disease Nho, Kwangsik
2013
9 4S p. P554-P555
artikel
1102 Imaging microglial activation in a mouse model of Alzheimer's disease using PET/MRI and ex vivo autoradiography James, Michelle
2013
9 4S p. P338-P339
artikel
1103 Imaging of α4β2 nicotinic acetylcholine receptors in neurodegenerative disorders using 2-[18F]F-A85380 and [18F]Flubatine Sabri, Osama
2013
9 4S p. P514-P515
artikel
1104 Immunohistochemical study of the cerebellum in amyotrophic lateral screlosis (ALS)/ parkinson-dementia complex (PDC) in Kii peninsula (ALS/PDC- Kii, Muro disease) Morimoto, Satoru
2013
9 4S p. P336
artikel
1105 Immunolocalization of Smurf1 in Hirano bodies Makioka, Kouki
2013
9 4S p. P193-P194
artikel
1106 Immunological dysfunction and MCI-like behavior in the 3xTgAD mice Marchese, Monica
2013
9 4S p. P161
artikel
1107 Immunomodulation targeting pathology-associated protein conformers in 3xTg and TgSwDI mice Goni, Fernando
2013
9 4S p. P847
artikel
1108 Immunotherapy targeting human wild type and P301L tau results in an immune response and changes in tau levels in an rTG4510 mouse model Selenica, Maj-Linda
2013
9 4S p. P509-P510
artikel
1109 Impact and blast neurotrauma mouse models of chronic traumatic encephalopathy validated by human neuropathology Fisher, Andrew
2013
9 4S p. P141
artikel
1110 Impact of an Alzheimer’s society and primary care partnership: A survey of health care providers Lee, Linda
2013
9 4S p. P118
artikel
1111 Impact of disinhibition and apathy on progression from mild cognitive impairment to dementia Golimstok, Angel
2013
9 4S p. P772
artikel
1112 Impact of parallel imaging on volumetric brain MRI measurements in ADNI-GO and ADNI-2 Gouttard, Sylvain
2013
9 4S p. P272
artikel
1113 Impact of parallel imaging on volumetric brain MRI measurements in ADNI-GO and ADNI-2 Gouttard, Sylvain
2013
9 4S p. P100-P101
artikel
1114 Impaired adult hippocampal neurogenesis in a mouse model for Alzheimer’s disease Avila, Jesus
2013
9 4S p. P549
artikel
1115 Impaired risk cognition and post-disaster coping behavior among the old-old population in the community: The Tome Project—A preliminary study Nakamura, Kei
2013
9 4S p. P609-P610
artikel
1116 Impairments of 3D visual perception in posterior cortical atrophy: Psychophysical, structural and functional anatomical basis Gillebert, Celine R.
2013
9 4S p. P524
artikel
1117 Implications of brain microvessel endothelial cell–derived beta-amyloid peptide in cerebral amyloid angiopathy associated with Alzheimer's disease Mikawa, Ryuta
2013
9 4S p. P184-P185
artikel
1118 Importance of coincident neurodegenerative diseases Toledo, Jon
2013
9 4S p. P334
artikel
1119 Importance of vascular factors in the etiology and pathogenesis of Alzheimer's disease Maksimovich, Ivan
2013
9 4S p. P378-P379
artikel
1120 Improved cognitive behavior in an Alzheimer's model through multimodal reduction of tau phosphorylation and accumulation in hippocampus by orally available inhibitors of casein kinase 1 delta/epsilon Pike, Ian
2013
9 4S p. P885-P886
artikel
1121 Improved interpretation of amyloid tracer kinetic data through model-based analysis Stone, Julie
2013
9 4S p. P290-P291
artikel
1122 Improved PhosphoTau SRM assay sensitivity enables multisite tau phosphorylation quantitation in a preclinical model of Alzheimer's disease treated with novel small-molecule inhibitors of casein kinase 1 delta Lahert, Emma
2013
9 4S p. P893
artikel
1123 Improved precision of beta-amyloid measurements in nasal samples using a new collection instrument Nanjo, Toshifumi
2013
9 4S p. P213
artikel
1124 Improvement of the screening accuracy of the Mini-Mental State Examination for mild cognitive impairment and dementia by supplementation of verbal fluency performance Sohn, Bo Kyung
2013
9 4S p. P769
artikel
1125 Improving access to community services: Role of the Alzheimer Society in primary care–based memory clinics Lee, Linda
2013
9 4S p. P647
artikel
1126 Improving analytical performance of immunoassay methods Figurski, Michael
2013
9 4S p. P288-P289
artikel
1127 Improving cognition to improve gait in Alzheimer's disease: A complementary approach to reduce fall risk in the cognitively impaired Odasso, Manuel Montero
2013
9 4S p. P659
artikel
1128 Improving dementia care in primary care: Impact of a training program on physician practice patterns Sloane, Philip
2013
9 4S p. P633
artikel
1129 Improving fatigue-related driving: Differences for healthy older adults and those with MCI Song, Woojin
2013
9 4S p. P489
artikel
1130 Incidence and clinical progression of placebo-treated amyloid-negative subjects with mild-to-moderate Alzheimer's disease (AD): Results from the phase III PET substudies of bapineuzumab and solanezumab Salloway, Stephen
2013
9 4S p. P888-P889
artikel
1131 Incidence and predictors of response to the 13.3 (15 cm2) and 9.5 mg/24h (10 cm2) rivastigmine patch in the OPtimising Transdermal Exelon In Mild-to-moderate Alzheimer's disease (OPTIMA) study Molinuevo, Jose Luis
2013
9 4S p. P656-P657
artikel
1132 Increased cerebral blood flow in cognitively normal older adults with amyloid Schultz, Aaron
2013
9 4S p. P58-P59
artikel
1133 Increased cerebral blood flow in cognitively normal older adults with amyloid Schultz, Aaron
2013
9 4S p. P582-P583
artikel
1134 Increased functional connectivity is related to low performance and subjective memory complaints during working memory activation Macpherson, Helen
2013
9 4S p. P834
artikel
1135 Increased myeloperoxidase (MPO) plasma levels in patients with Alzheimer's disease Schreitmüller, Brigitte
2013
9 4S p. P235
artikel
1136 Increased oxygen extraction capacity in the basal ganglia and thalamus of patients with Alzheimer's disease Eskildsen, Simon
2013
9 4S p. P273-P274
artikel
1137 Increased oxygen extraction capacity in the basal ganglia and thalamus of people with Alzheimer's disease Eskildsen, Simon
2013
9 4S p. P102
artikel
1138 Increased posterior default mode network connectivity co-occurs with incident amyloidosis prior to declining in dementia Jones, David
2013
9 4S p. P522
artikel
1139 Increased sensitivity to pain in people with Alzheimer's disease Jensen-Dahm, Christina
2013
9 4S p. P291-P292
artikel
1140 Increasing age and CSF biomarker levels in Alzheimer's disease: The PLM study Dumurgier, Julien
2013
9 4S p. P205-P206
artikel
1141 Index of alpha/theta ratio of the electroencephalogram: A new marker for Alzheimer's disease Schmidt, Magali
2013
9 4S p. P368
artikel
1142 Indications and use of CSF biomarkers in French memory clinics Mouton-Liger, François
2013
9 4S p. P212
artikel
1143 Individual subject classification of mixed dementia versus pure subcortical vascular dementia based on subcortical shape analysis Kim, Hee-Jin
2013
9 4S p. P268-P269
artikel
1144 Individuals with Alzheimer's disease exhibit a high prevalence of undiagnosed impaired glucose tolerance and type 2 diabetes mellitus Turner, Raymond
2013
9 4S p. P284-P285
artikel
1145 Inflammation markers in CSF and MRI spectroscopy in Alzheimer's disease pre-dementia stages Alcolea, Daniel
2013
9 4S p. P219-P220
artikel
1146 Inflammatory pathways link amyloid and tau pathology Lamb, Bruce
2013
9 4S p. P315
artikel
1147 Influence of acculturation on depression among Latina/o caregivers of people with Alzheimer's disease Alvarez, Paula
2013
9 4S p. P487
artikel
1148 Influence of amyloid deposition on cerebral glucose metabolism in mild cognitive impairment subjects Fan, Zhen
2013
9 4S p. P602
artikel
1149 Influence of chronic pain and stress on cognitive function: 5-HT6 antagonist improves the behavioral outcome in rats Nirogi, Ramakrishna
2013
9 4S p. P158
artikel
1150 Influence of PARP1 haplotype on [11C]PBR28 PET brain uptake Kim, Sungeun
2013
9 4S p. P706-P707
artikel
1151 Influence of PARP1 haplotype on [11C]PBR28 PET brain uptake Kim, Sungeun
2013
9 4S p. P84-P85
artikel
1152 Infrequent skin reactions at the application site of the rivastigmine patch (4.6, 9.5 or 13.3 mg/24 h): Analysis of two clinical studies revealed most were tolerable and manageable across all doses Alva, Gustavo
2013
9 4S p. P666
artikel
1153 Inhibition of BACE1 reduces beta-amyloid 1-40 but not N-terminal-truncated beta-amyloid Atchison, Kevin
2013
9 4S p. P190
artikel
1154 Inhibition of glycogen synthase kinase-3β improves cognitive deficits and tau hyperphosphorylation induced by cerebral ischemia-reperfusion in rats Yao, Xiu-Qing
2013
9 4S p. P713-P714
artikel
1155 Inhibition of the CAMKK2-AMPK-tau signaling pathway protects hippocampal neurons from beta-amyloid oligomer–induced synaptotoxicity Mairet-Coello, Georges
2013
9 4S p. P577
artikel
1156 Initial evaluation of fully automated, chemiluminescent beta-amyloid 42 and tau assays Simon, Adam
2013
9 4S p. P214
artikel
1157 Innate immunity stimulation via TLR9 in a non-human primate model of sporadic cerebral amyloid angiopathy Scholtzova, Henrieta
2013
9 4S p. P508
artikel
1158 In sickness and in health: Coregulation of spousal caregivers' and dementia patients' cortisol levels, relationship quality and health outcomes Hodgson, Nancy
2013
9 4S p. P481
artikel
1159 Insoluble TDP-43 prepared from diseased brains has prion-like properties Nonaka, Takashi
2013
9 4S p. P720
artikel
1160 Insomnia in caregivers of people with Alzheimer's disease Janjic, Vladimir
2013
9 4S p. P484
artikel
1161 Instrumental activities of daily living (IADL) assessments used by occupational therapists in the management of individuals with mild cognitive impairment Belchior, Patricia
2013
9 4S p. P118
artikel
1162 Integrated medical and case management dementia model Noel, Margaret
2013
9 4S p. P118
artikel
1163 Integrated services for dementia: The formal carer experience Woolrych, Ryan
2013
9 4S p. P528
artikel
1164 Integrating comprehensive dementia care into the medical home: The geriatrics in primary care demonstration Engel, Peter
2013
9 4S p. P118-P119
artikel
1165 Interaction of chaperones with APP695 Bose, Meenakshi
2013
9 4S p. P180-P181
artikel
1166 Interactive calendar Gang, Vanessa
2013
9 4S p. P480-P481
artikel
1167 Interactome analyses of mature gamma-secretase complexes reveals distinct molecular environments of presenilin paralogs and preferential binding of signal peptide peptidase to PS2 Boehm, Christopher
2013
9 4S p. P364
artikel
1168 Interference of cognitive disorders in everyday life: The diagnostic accuracy of a new Instrumental Activities of Daily Living instrument Sikkes, Sietske
2013
9 4S p. P736
artikel
1169 Intergrating human and fly genetics to understand Alzheimer's disease susceptibility Imboywa, Selina
2013
9 4S p. P356
artikel
1170 Inter-laboratory variation when using a unified test procedure for INNO-BIA AlzBio3 Vandijck, Manu
2013
9 4S p. P209-P210
artikel
1171 Interleukin-6 (IL-6) is associated with longitudinal rates of cortical thinning McCarrey, Anna
2013
9 4S p. P307
artikel
1172 International, multicenter training and validation of CSF Alzheimer's biomarker assays Oberoi, Pankaj
2013
9 4S p. P242
artikel
1173 Interventions for severe agitation in a 67-year-old combat veteran with severe dementia Kleczek, Agnieszka
2013
9 4S p. P478
artikel
1174 Intracerebroventricular administration of streptozotocin exacerbates cognitive deficits and brain abnormalities of 3xTg-AD mice Chen, Yanxing
2013
9 4S p. P566
artikel
1175 Intracranial administration of Gammagard IVIg lowers amyloid and modulates neuroinflammatory profiles along a different time-course than anti-beta-amyloid IgG: Implications for mechanism of action Wilcock, Donna
2013
9 4S p. P162
artikel
1176 Intra-hippocampal administration of beta-amyloid decreases ERK phosphorylation in the hippocampus of rat Moosavi, Maryam
2013
9 4S p. P183
artikel
1177 Intranasal immunization with 3A1 antibody reduced cerebral beta-amyloid multimers in 5XFAD mice Chauhan, Neelima
2013
9 4S p. P358-P359
artikel
1178 Intravenous immunoglobulin shifts microglial activation state toward anti-inflammatory activity and reverses beta-amyloid–mediated LTP inhibition Cattepoel, Susann
2013
9 4S p. P818
artikel
1179 Investigating biological mechanisms of corticosterone-induced neurodegeneration: Implication of how depression promotes cognitive impairment in Alzheimer's disease Chuen-Chung Chang, Raymond
2013
9 4S p. P561-P562
artikel
1180 Investigating nuclear hormone receptors as a target for Alzheimer's disease Iyer, Sangeetha
2013
9 4S p. P562
artikel
1181 Investigations of brain glucose utilization in three transgenic mouse strains that develop neuropathological features of Alzheimer's disease Kelley, Jonathan
2013
9 4S p. P329
artikel
1182 In vitro characterization of [3H]-T808 (tau PET tracer) binding in human brain tissues in Alzheimer's disease Chen, Tsing-Bau
2013
9 4S p. P101
artikel
1183 In vitro characterization of [3H]-T808 (tau PET tracer) binding in human brain tissues of Alzheimer's disease Zeng, Zhizhen
2013
9 4S p. P260
artikel
1184 In vivo characterization of glutamatergic vulnerability in behavioral variant FTD: An [11C]ABP688 PET/ VBM /DBM study Leuzy, Antoine
2013
9 4S p. P9-P10
artikel
1185 In vivo characterization of metabotropic glutamate receptor type five vulnerability in behavioral variant FTD and Alzheimer's disease: An [11C]ABP688 PET/ VBM /DBM study Leuzy, Antoine
2013
9 4S p. P846
artikel
1186 In vivo detection of cholinergic basal forebrain atrophy using cytoarchitectonic mappings and multimodal imaging approaches Grothe, Michel
2013
9 4S p. P514
artikel
1187 In vivo detection of tau protein deposits in Alzheimer's disease using 18F-labeled 2-phenylquinoline derivatives Okamura, Nobuyuki
2013
9 4S p. P268
artikel
1188 In vivo Gd-staining MRI reveals efficacy of anti-beta-amyloid immunotherapy after longitudinal study in a transgenic mouse model of Alzheimer's disease Santin, Mathieu
2013
9 4S p. P505
artikel
1189 In vivo Gd-staining MRI reveals efficacy of anti-beta-amyloid immunotherapy after longitudinal study in a transgenic mouse model of Alzheimer's disease Santin, Mathieu
2013
9 4S p. P20
artikel
1190 In vivo injection of an amyloid-42 inducer (Aftin-4), a roscovitine-related purine, induces Alzheimer's disease–related toxicity in the mouse brain Meunier, Johann
2013
9 4S p. P496
artikel
1191 In vivo pattern of tau and beta-amyloid deposition in the brain might distinguish healthy controls from preclinical Alzheimer's disease Villemagne, Victor
2013
9 4S p. P534
artikel
1192 In vivo pattern of tau and beta-amyloid deposition in the brain might distinguish healthy individuals from those with preclinical Alzheimer's disease Villemagne, Victor
2013
9 4S p. P94
artikel
1193 In vivo tau spreading relies on the transsynaptic transfer of soluble wild-type tau species Buee, Luc
2013
9 4S p. P142
artikel
1194 In vivo visualization of tau pathology Shimada, Hitoshi
2013
9 4S p. P101-P102
artikel
1195 In vivo visualization of tau pathology in Alzheimer's disease patients by [11C]PBB3-PET Shimada, Hitoshi
2013
9 4S p. P845
artikel
1196 Involvement of 5lipoxygenase in Alzheimer's disease tau neuropathology Pratico, Domenico
2013
9 4S p. P713
artikel
1197 IPAF inflammasome in astrocyte enhances neurotoxicity: A novel target for Alzheimer's disease Liu, Li
2013
9 4S p. P350
artikel
1198 IRAK-M deletion promotes microglia-mediated beta-amyloid phagocytosis in PSAPP mice Gate, David
2013
9 4S p. P161-P162
artikel
1199 Is a family history of dementia associated with high aortic stiffness? Pase, Matthew
2013
9 4S p. P230
artikel
1200 Is dementia incidence declining? The snac-K study Fratiglioni, Laura
2013
9 4S p. P511
artikel
1201 Is hippocampal volume a good marker to differentiate Alzheimer's disease from frontotemporal dementia? de Souza, Leonardo
2013
9 4S p. P380-P381
artikel
1202 Is there a link between novel retinal and cerebral markers of microvascular pathology? Ikram, Mohammad Kamran
2013
9 4S p. P836-P837
artikel
1203 Is there a link between open-angle glaucoma and dementia? Results from a prospective population-based cohort study Helmer, Catherine
2013
9 4S p. P756-P757
artikel
1204 Is the severity of dilated Virchow-Robin spaces associated with cognitive function? Jeong, Eun Hye
2013
9 4S p. P589
artikel
1205 Is verbal episodic memory in elderly individuals with amyloid deposits preserved through altered neuronal function? Ossenkoppele, Rik
2013
9 4S p. P392
artikel
1206 Item Response Theory models for cognitive performance data in ADNI Jones, Richard
2013
9 4S p. P124-P125
artikel
1207 IVIG reduces tau pathology and increases neuroplastic gene expression in the 3xTg mouse model of Alzheimer's disease Counts, Scott
2013
9 4S p. P356
artikel
1208 KIF6 719Arg carrier status association with homocysteine and C-reactive protein in mild cognitive impairment and Alzheimer's disease Malek-Ahmadi, Michael
2013
9 4S p. P243
artikel
1209 Kinetics of CNS APP metabolites in the presence of a BACE1 inhibitor in a non-human primate model Dobrowolska, Justyna
2013
9 4S p. P151-P152
artikel
1210 Klotho gene protects primary hippocampal neurons from oxidative stress Zeldich, Ella
2013
9 4S p. P575
artikel
1211 Known preclinical dementia influences normative samples as evidenced by a longitudinal study: Results from the Einstein Aging Study Mowrey, Wenzhu
2013
9 4S p. P796
artikel
1212 Lack of agreement between biomarkers of neuronal injury in ADNI Kriett, Laura
2013
9 4S p. P217-P218
artikel
1213 Language and speech impairment in clinical dementia with Lewy bodies: Clinical features and possible pathophysiology Fukui, Toshiya
2013
9 4S p. P732-P733
artikel
1214 Language-variant Alzheimer's disease: Defining early clinical and imaging characteristics of logopenic progressive aphasia Domoto-Reilly, Kimiko
2013
9 4S p. P52-P53
artikel
1215 Language-variant Alzheimer's disease: Defining early clinical and imaging characteristics of logopenic progressive aphasia Domoto-Reilly, Kimiko
2013
9 4S p. P423-P424
artikel
1216 Large-system change: Improving behavioral services in Ontario Harvey, David
2013
9 4S p. P476
artikel
1217 Late-life cognitive activity and brain diffusion characteristics in nondemented elderly Barth, Christopher
2013
9 4S p. P543
artikel
1218 Late-life cynical distrust, incident dementia and mortality Tolppanen, Anna-Maija
2013
9 4S p. P607
artikel
1219 Late-onset Alzheimer's disease genetic risk factors in two Canadian cohorts: CSHA and ACCORD Omoumi, Ardeshir
2013
9 4S p. P551-P552
artikel
1220 Late-onset Alzheimer’s disease neuropathology genomic screen identifies novel loci for neuritic plaque and other Alzheimer’s neuropathology features Beecham, Gary
2013
9 4S p. P693
artikel
1221 Lavender essential oil improves sleep in residents of a memory care assisted living facility Hanson, Leah
2013
9 4S p. P655-P656
artikel
1222 Learning slope in mild cognitive impairment is associated with medial temporal lobe grey matter volume Phillips, Jeffrey
2013
9 4S p. P786
artikel
1223 Lenalidomide as an antineuroinflammatory and BACE1 inhibitor: Pilot study on APP23 mice Decourt, Boris
2013
9 4S p. P163
artikel
1224 Leptin and the risk of progression to Alzheimer's disease among Chinese older adults with amnestic mild cognitive impairment Chu, Leung-wing
2013
9 4S p. P202
artikel
1225 Lessons for predicting incident dementia by memory testing Grober, Ellen
2013
9 4S p. P536-P537
artikel
1226 Lewy body spectrum disorders: Neuroimaging Brooks, David
2013
9 4S p. P311
artikel
1227 Licofelone: A dual COX/5-LOX inhibitor attenuates intracerebroventricular streptozotocin-induced cognitive deficit, oxidative stress and neuro-inflammatory cytokines in rats Deshmukh, Rahul
2013
9 4S p. P302
artikel
1228 Life-span cognitive activity, neuropathologic burden and cognitive aging James, Bryan
2013
9 4S p. P625
artikel
1229 Lifestyle factors in Alzheimer's disease: Physical activity is the best predictor of executive function Farina, Nicolas
2013
9 4S p. P791
artikel
1230 Ligand for translocator protein increases hippocampal expression of glial beta-amyloid scavenger receptors and reduces beta-amyloid in male mice and rats Barron, Anna
2013
9 4S p. P703
artikel
1231 Light therapy for improving cognitive, sleep, functional, behavioural or mood disturbances in dementia: A Cochrane review Forbes, Dorothy
2013
9 4S p. P661-P662
artikel
1232 Limited literacy predicts dementia incidence among older adults Kaup, Allison
2013
9 4S p. P628
artikel
1233 Linking declining levels of plasma beta-amyloid 42 to Alzheimer's disease: The role of cerebral microbleeds Brickman, Adam
2013
9 4S p. P129
artikel
1234 Local inflammatory response associated with beta-amyloid deposition in the retina of Alzheimer's disease and MCI patients Koronyo, Yosef
2013
9 4S p. P231-P232
artikel
1235 Localized cerebral atrophy acceleration during Alzheimer’s disease Pai, Akshay
2013
9 4S p. P151
artikel
1236 Localized cerebral atrophy acceleration during Alzheimer's disease Pai, Akshay
2013
9 4S p. P36-P37
artikel
1237 Long-acting intranasal insulin detemir improves working memory for adults with mild cognitive impairment or early-stage Alzheimer's dementia Claxton, Amy
2013
9 4S p. P657
artikel
1238 Longitudinal assessment of mitochondrial DNA copy number and deletion ratio in peripheral blood of people with Alzheimer's: A Texas Alzheimer's Research and Care Consortium Project Phillips, Nicole
2013
9 4S p. P206
artikel
1239 Longitudinal changes in white matter disease and cognition in subcortical vascular mild cognitive impairment Kim, Hee-Jin
2013
9 4S p. P837
artikel
1240 Longitudinal changes of MRI marker in Alzheimer's disease and frontotemporal dementia Frings, Lars
2013
9 4S p. P669
artikel
1241 Longitudinal cognitive changes in visual, verbal and visual-verbal amnestic mild cognitive impairment Ye, Byoung Seok
2013
9 4S p. P768-P769
artikel
1242 Longitudinal cognitive training in people with mild cognitive impairment Tsolaki, Magda
2013
9 4S p. P491-P492
artikel
1243 Longitudinal evaluation of basal forebrain atrophy and its association to beta-amyloid burden and hippocampal volume in Alzheimer's disease Kerbler, Georg
2013
9 4S p. P533
artikel
1244 Longitudinal evaluation of basal forebrain atrophy and its association with beta-amyloid burden and hippocampal volume in Alzheimer's disease Kerbler, Georg
2013
9 4S p. P53
artikel
1245 Longitudinal gray matter loss and diffusion anisotropy changes in mild cognitive impairment Zhang, Yu
2013
9 4S p. P702
artikel
1246 Longitudinal gray matter loss and diffusion anisotropy changes in mild cognitive impairment Zhang, Yu
2013
9 4S p. P53-P54
artikel
1247 Longitudinal hippocampal atrophy is associated with hippocampus functional connectivity changes in cognitively normal elders He, Jing
2013
9 4S p. P399-P400
artikel
1248 Longitudinal multi-tracer positron emission tomography studies of astrocytosis, fibrillar amlyloid deposition and cerebral glucose metabolism during development of early-onset familial Alzheimer's disease Schöll, Michael
2013
9 4S p. P695
artikel
1249 Longitudinal structural and functional brain connectivity assessment in presymptomatic familial frontotemporal dementia Dopper, Elise
2013
9 4S p. P81
artikel
1250 Longitudinal structural and functional brain connectivity assessment in presymptomatic familial frontotemporal dementia Dopper, Elise
2013
9 4S p. P835
artikel
1251 Long-term cumulative depressive symptom burden and risk of cognitive decline and dementia among very old women Al Hazzouri, Adina Zeki
2013
9 4S p. P607-P608
artikel
1252 Long-term effects on cognitive function of postmenopausal hormone therapy prescribed to women aged 50-54 years: Results from the Women's Health Initiative Memory Study of Younger Women (WHIMSY) Espeland, Mark
2013
9 4S p. P529-P530
artikel
1253 Long-term patterns of low physical activity and cognitive function in mid-life: the CARDIA Study Hoang, Tina
2013
9 4S p. P134-P135
artikel
1254 Long-term treatment with cholinesterase inhibitors restores homeostatic levels of calcium-independent PLA2: Evidence of disease-modification in Alzheimer's disease Talib, Leda
2013
9 4S p. P347
artikel
1255 Looking for world-wide pictures that patients with alzheimer's disease find it difficult to name? Help and join us! Bartos, Ales
2013
9 4S p. P789-P790
artikel
1256 Losartan-induced hypotension impairs learning and memory Xinghua, Liu
2013
9 4S p. P575
artikel
1257 Loss of global and local efficiency in the dorsal default-mode and visuospatial network in cognitively intact individuals who are beta-amyloid-positive Mueller, Susanne
2013
9 4S p. P390
artikel
1258 Loss of tau function leads to cognitive deficits and synapse loss with aging Ma, Qiulan
2013
9 4S p. P719-P720
artikel
1259 Loss of tau induces age-dependent anaemia with reduced longevity in mice Lei, Peng
2013
9 4S p. P716
artikel
1260 Low doses of lithium increased intra- and extracellular brain-derived neurotrophic factor (BDNF) and tumor necrosis factor (TNF) α in cortical and hippocampal neuron cell culture De Paula, Vanessa
2013
9 4S p. P569
artikel
1261 Low education, brain weight and dementia: Evidence for neural reserve Farfel, Jose
2013
9 4S p. P634-P635
artikel
1262 Lower knowledge of Alzheimer's disease is associated with higher risk for adverse outcomes in Latino caregivers Nevarez, Johanna
2013
9 4S p. P547
artikel
1263 Lower plasma nutrient levels in people with mild Alzheimer's disease compared with healthy volunteers Marcel, Olde Rikkert
2013
9 4S p. P670
artikel
1264 Low-grade inflammatory processes stimulate regenerative mechanisms in Alzheimer’s disease Malmsten, Linn
2013
9 4S p. P547-P548
artikel
1265 Low platelet PLA2 activity predicts conversion from mild cognitive impairment to Alzheimer's disease: A 4-year follow-up study Gattaz, Wagner
2013
9 4S p. P347
artikel
1266 L-type calcium channel blockers rescue beta-amyloid-42–induced neurotoxicity by inhibiting CREB and CDK5 activation Qing, Hong
2013
9 4S p. P192
artikel
1267 Machine-learning classification of MR scans in Alzheimer's disease based on tensor-based morphometry Fujishima, Motonobu
2013
9 4S p. P375
artikel
1268 Magnetic resonance imaging and Alzheimer's disease: Longitudinal studies of structural and metabolic changes in different transgenic mice models Micotti, Edoardo
2013
9 4S p. P246
artikel
1269 Mammalian silent information regulator two homologue (type 2): Immunocytochemical study in rat models of neurodegenerative disease Raheem, Ahmed
2013
9 4S p. P353-P354
artikel
1270 Manual segmentation certification platform for the EADC-ADNI harmonized protocol for the hippocampal volumetry project Duchesne, Simon
2013
9 4S p. P409-P410
artikel
1271 MAPT methylation and implications for late-onset Alzheimer's disease Coupland, Kirsten
2013
9 4S p. P852-P853
artikel
1272 Mastery, stress and psychological health in dementia caregivers McAuliffe, Linda
2013
9 4S p. P324
artikel
1273 Matrix metalloproteinase-3 is associated with decreased plasma gelsolin in Alzheimer's disease Jia, Jianping
2013
9 4S p. P572
artikel
1274 Measuring Alzheimer's disease knowledge in Missouri Hurwicz, Margo-Lea
2013
9 4S p. P641-P642
artikel
1275 Measuring axonal transport in aging mice with and without beta-amyloid plaques induced by mutant APP expression Bearer, Elaine
2013
9 4S p. P190
artikel
1276 Mechanism of action of the specific nutrient combination Fortasyn® Connect, which is designed to enhance synapse formation and function in Alzheimer's disease Wieggers, R.L.
2013
9 4S p. P802
artikel
1277 Mechanism of aggravation of PP2A inhibition and apoptosis by the phosphor-mimic I2PP2A/SET Yu, Guang
2013
9 4S p. P567-P568
artikel
1278 Mechanism of tau transfer: Insights from cell culture and animal models Wu, Jessica
2013
9 4S p. P856
artikel
1279 Media coverage and the evolution of Alzheimer's disease in the public mind Coughlin, Joseph
2013
9 4S p. P470-P471
artikel
1280 Medial temporal lobe changes preceding symptom onset of mild cognitive impairment: The BIOCARD Cohort Miller, Michael I.
2013
9 4S p. P54
artikel
1281 Medical and Scientific Advisory Council 2013
9 4S p. A7
artikel
1282 Medication and the brain: Polypharmacy is related to grey- and white-matter volume loss in an elderly population visiting a memory clinic Meulenbroek, Olga
2013
9 4S p. P435
artikel
1283 Medication persistence and discontinuation in dementia 3 years after initial diagnosis: A multicenter retrospective analysis Jeong, Jee-Hyang
2013
9 4S p. P288
artikel
1284 Melatonin attenuates scopolamine-induced memory/synaptic disorder by rescuing EPACs/miR-124/Egr1 pathway Wang, Xiong
2013
9 4S p. P711
artikel
1285 Melatonin supplement only at specific timing rescues the pathology and memory deficits in tg2576 mice via targeting GSK-3 Peng, Caixia
2013
9 4S p. P346
artikel
1286 Memantine and comprehensive, individualized, person-centered management (CI-PCM) of Alzheimer's disease: A randomized controlled trial Reisberg, Barry
2013
9 4S p. P295-P296
artikel
1287 Memantine improves attention and verbal episodic memory in Parkinson's disease dementia and dementia with Lewy bodies: A double-blind, placebo-controlled multicentre trial Wesnes, Keith
2013
9 4S p. P890
artikel
1288 Memantine in Alzheimer's disease Reich, Edgardo
2013
9 4S p. P302
artikel
1289 Memantine-induced rapid deterioration of vision: A case report Ergin, Nesrin
2013
9 4S p. P732
artikel
1290 Memantine prevents the reference and working memory impairment caused by sleep deprivation in Octodon degus, a potential animal model for Alzheimer's disease Cros, Ernesto Tarragon
2013
9 4S p. P156
artikel
1291 Memory complaints and depressive symptoms as predictors of dementia in a biracial community-based sample: Results from the Einstein Aging Study Garland, Alejandra
2013
9 4S p. P626
artikel
1292 Memory evaluation of people with Alzheimer's disease using the Montreal Cognitive Assessment Bartos, Ales
2013
9 4S p. P449
artikel
1293 Memory performance of past public events depends on retrieval frequency but not remoteness in Alzheimer's disease Leyhe, Thomas
2013
9 4S p. P277-P278
artikel
1294 Memory screening for aMCI and dementia in Latinos Grober, Ellen
2013
9 4S p. P322-P323
artikel
1295 Memory training in healthy elderly and seniors with mild cognitive impairment: Benefits on cognitive parameters Brum, Paula
2013
9 4S p. P493
artikel
1296 Mental health symptoms in people with cognitive impairment and memory loss and their caregivers: Initial findings and implications for counselors and geriatricians Hall, Daniel
2013
9 4S p. P485-P486
artikel
1297 Meta-analysis in more than 74,000 individuals identifies 11 new susceptibility loci for Alzheimer's disease Lambert, Jean-Charles
2013
9 4S p. P123
artikel
1298 Metabolic abnormalities in Alzheimer's disease and semantic dementia involve distinct functional networks overlapping in the hippocampus La Joie, Renaud
2013
9 4S p. P388-P389
artikel
1299 Metabolic abnormalities in Alzheimer's disease and semantic dementia involve distinct functional networks overlapping in the hippocampus La Joie, Renaud
2013
9 4S p. P113
artikel
1300 Methemoglobin catabolism and Alzheimer's disease Mohorovic, Lucijan
2013
9 4S p. P861
artikel
1301 Mice develop B-lymphocyte–dependent delayed cognitive deficits weeks after stroke Doyle, Kristian
2013
9 4S p. P157
artikel
1302 Microbleeds and clinical trajectories: Results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging Yates, Paul
2013
9 4S p. P131
artikel
1303 Microglia constitute a barrier that prevents the formation of neurotoxic oligomeric beta-amyloid hot spots around plaques Condello, Carlo
2013
9 4S p. P351
artikel
1304 Microglial involvement and amyloid reduction with BAN2401/mAb158, a monoclonal antibody with high selectivity for protofibrils: In vitro and ex vivo analyses Kaplow, June M.
2013
9 4S p. P807-P808
artikel
1305 Micrography in Alzheimer's disease Moraes, Fabiano
2013
9 4S p. P758-P759
artikel
1306 MicroRNA biomarkers in Alzheimer's disease Mistrellides, Costas
2013
9 4S p. P224
artikel
1307 MicroRNA complexity in Alzheimer's disease cerebrospinal fluid, extracellular fluid and brain tissue biopsy Lukiw, Walter
2013
9 4S p. P351-P352
artikel
1308 MicroRNAs that silence tau expression are dysregulated in Alzheimer's disease Santa-Maria, Ismael
2013
9 4S p. P854
artikel
1309 MicroRNA-346 stimulates APP expression by blockading an iron response element in the APP 5'-UTR: A novel therapeutic target for Alzheimer's disease (AD) Lahiri, Debomoy
2013
9 4S p. P839
artikel
1310 Midlife adiposity and FTO genotype: State and trait predictors of brain function during aging Chuang, Yi-Fang
2013
9 4S p. P842-P843
artikel
1311 Midlife insulin resistance is associated with hypometabolism on FDG-PET Bendlin, Barbara
2013
9 4S p. P411-P412
artikel
1312 Midlife problem drinking and risk of cognitive decline and dementia: An 18-year prospective cohort study Kuzma, Elzbieta
2013
9 4S p. P837
artikel
1313 Midlife vascular risk and late-life amyloid burden: Data from the Women's Healthy Ageing Project (WHAP) Yates, Paul
2013
9 4S p. P544-P545
artikel
1314 Mild blast exposure induces early and persistent aberrant phospho- and cleaved tau expression in mice Huber, Bertrand R.
2013
9 4S p. P141
artikel
1315 Mild cognitive impairment associated with nonamyloid biomarker findings Ossenkoppele, Rik
2013
9 4S p. P122
artikel
1316 Mild cognitive impairment subtypes: An MEG study Cabranes, Jose Antonio
2013
9 4S p. P376
artikel
1317 Mild-intensity exercise regimen preserves cerebral perfusion in precuneus and prefrontal regions in the elderly Nemoto, Kiyotaka
2013
9 4S p. P396
artikel
1318 Mild total hypercholesterolemia, elevated serum high-density and non-high-density lipoproteins, across age and disease severity staging, in people with Alzheimer's disease: An observational study Ramdane, Said
2013
9 4S p. P232
artikel
1319 MiR128 up-regulation correlates with impaired beta-amyloid 42 degradation in monocytes of patients with sporadic Alzheimer's disease Tiribuzi, Roberto
2013
9 4S p. P195
artikel
1320 Misdiagnosis using brief cognitive screening instruments in a population-representative sample Plassman, Brenda
2013
9 4S p. P784-P785
artikel
1321 Missing data and the identification of optimal predictors of conversion to Alzheimer's disease Dowling, Maritza
2013
9 4S p. P776-P777
artikel
1322 Mitochondrial genetic variation is associated with brain imaging markers of Alzheimer's disease neurodegeneration Ridge, Perry
2013
9 4S p. P206
artikel
1323 Mitochondrial genome-wide association study of Alzheimer's disease Hudson, Gavin
2013
9 4S p. P550
artikel
1324 Mitophagy pathway is induced by alginate oligosaccharide in PC12 cells exposed to oxidative stress Tusi, Solaleh Khoramian
2013
9 4S p. P307
artikel
1325 Mixed linear longitudinal modeling of biomarkers in ADNI Mouiha, Abderazzak
2013
9 4S p. P34
artikel
1326 Mixed linear longitudinal modeling of biomarkers in ADNI Abderazzak, Mouiha
2013
9 4S p. P202-P203
artikel
1327 Mixture models for sequences of events in Alzheimer's disease progression Beckett, Laurel
2013
9 4S p. P677
artikel
1328 Model-based meta-analysis of the efficacy of cholinesterase inhibitors and memantine in mild-to-moderate Alzheimer's disease as assessed by ADAS-Cog scores Agarwal, Sagar
2013
9 4S p. P292
artikel
1329 Modeling Alzheimer's disease using induced pluripotent stem cells from familial and sporadic Alzheimer's disease patients Shirotani, Keiro
2013
9 4S p. P184
artikel
1330 Modeling Alzheimer's disease using iPS cells reveals stress phenotypes associated with intracellular beta-amyloid oligomer and differential drug responsiveness Asai, Masashi
2013
9 4S p. P185
artikel
1331 Modeling and elucidating the pathobiology of blast-induced traumatic brain injury in the mouse Fisher, Andrew
2013
9 4S p. P565
artikel
1332 Modeling and elucidating the pathobiology of impact induced traumatic brain injury in the mouse Tagge, Chad
2013
9 4S p. P565-P566
artikel
1333 Modeling of clinical measures to predict florbetapir F18 PET results in mild and moderate Alzheimer's dementia Witte, Michael
2013
9 4S p. P266
artikel
1334 Mode of action of the Alzheimer's disease–derived, highly toxic, high-mass, beta-amyloid assembly amylospheroid Ohnishi, Takayuki
2013
9 4S p. P577
artikel
1335 Modest reductions in BACE1 activity significantly reduce beta-amyloid plaque load and neuroinflammation in a mouse model of Alzheimer's disease Meilandt, William
2013
9 4S p. P504
artikel
1336 Modulation of beta-amyloid-related cognitive decline by brain-derived neurotrophic factor Val66Met polymorphism in preclinical Alzheimer's disease Lim, Yen Ying
2013
9 4S p. P446-P447
artikel
1337 Modulation of peripheral immune cell traffic to the CNS by XPro1595 in a mouse model of Alzheimer's disease MacPherson, Kathryn
2013
9 4S p. P160-P161
artikel
1338 Molecular neuropathology in Alzheimer's disease without dementia: Focus on synapses Arnold, Steven
2013
9 4S p. P827
artikel
1339 Monetary decision-making in behavioral variant frontotemporal dementia and Alzheimer's disease Wood, Kristie
2013
9 4S p. P753
artikel
1340 Monitoring effectiveness of Alzheimer's disease treatment by means of the Tomography Dementia Rating (TDR) scale Maksimovich, Ivan
2013
9 4S p. P249-P250
artikel
1341 Monoclonal antibody therapy targeting the shared pathological conformer of both beta-amyloid and hyperphosphorylated tau Goni, Fernando
2013
9 4S p. P839
artikel
1342 Months backward test as a reliable predictor of cognitive decline in mild Alzheimer's disease Tardif, Marissa
2013
9 4S p. P741-P742
artikel
1343 More white matter hyperintensities and smaller brain volumes are related to lower cerebral blood flow as measured with 3T arterial spin labeling MRI Benedictus, Marije
2013
9 4S p. P50
artikel
1344 More white matter hyperintensities and smaller brain volumes are related to lower cerebral blood flow measured with 3T arterial spin labeling magnetic resonance imaging Benedictus, Marije
2013
9 4S p. P700
artikel
1345 Morphological alterations in Alzheimer's disease and their possible relationship to defective neurodevelopment Tristán, María
2013
9 4S p. P876-P877
artikel
1346 Morphometric analysis of the retina in a triple-transgenic model of Alzheimer's disease Chiu, Kin
2013
9 4S p. P435
artikel
1347 Morphometric evidence of neuroplastic effects induced by intensive cognitive stimulation in healthy ageing and in mild cognitive impairment De Marco, Matteo
2013
9 4S p. P817
artikel
1348 Mortality from Alzheimer's disease in Sao Paulo and rio de janeiro Teixeira, Jane
2013
9 4S p. P881-P882
artikel
1349 Motor dysfunction in the 12-month-old 5xFAD mouse model of Alzheimer's disease O'Leary, Tim
2013
9 4S p. P497
artikel
1350 Motor function and cognition in the Israel Diabetes and Cognitive Decline study Guerrero-Berroa, Elizabeth
2013
9 4S p. P620
artikel
1351 Mouse models and ES cells for Alzheimer's disease research Sasner, Michael
2013
9 4S p. P497
artikel
1352 MR elastography of frontotemporal dementia Huston, John
2013
9 4S p. P102-P103
artikel
1353 MR elastography of frontotemporal dementia Huston, John
2013
9 4S p. P278-P279
artikel
1354 MRI and FDG-PET changes in normal aging across the adult lifespan Goldowsky, Alexander
2013
9 4S p. P395
artikel
1355 MRI and PiB-PET in asymptomatic adults with Down syndrome Handen, Ben
2013
9 4S p. P513-P514
artikel
1356 MRI findings in early stage of dementia with Lewy bodies Watanabe, Chigusa
2013
9 4S p. P876
artikel
1357 MR imaging of structural alterations in the brain of mice lacking PS1 and PS2 in the forebrain Venkatasubramanian, Palamadai
2013
9 4S p. P81-P82
artikel
1358 MR imaging of structural alterations in the brains of mice lacking PS1 and PS2 in the forebrain Venkatasubramanian, Palamadai
2013
9 4S p. P164
artikel
1359 MRI using a voxel-based specific regional analysis system for Alzheimer's disease and magnetic resonance spectroscopy are useful methods for routine management of Alzheimer's disease Waragai, Masaaki
2013
9 4S p. P723-P724
artikel
1360 MR-less cortical surface-projection of PET images from 11C- and 18F-labeled radiotracers Doré, Vincent
2013
9 4S p. P18-P19
artikel
1361 MRS differentiates MCI patients who progress to dementia with Lewy bodies and Alzheimer's disease Zhang, Bing
2013
9 4S p. P37
artikel
1362 MRS differentiates people with MCI who progress to dementia with Lewy bodies from people who progress to Alzheimer's disease Zhang, Bing
2013
9 4S p. P374
artikel
1363 Multicenter phase II trial of florbetaben beta-amyloid PET imaging in Alzheimer's disease: Results in a close to clinically routine situation Sabri, Osama
2013
9 4S p. P264
artikel
1364 Multicenter subcortical vascular dementia on FDG-PET (VADAPET) study signifies more posterior network hypometabolism Jeong, Jee-Hyang
2013
9 4S p. P750-P751
artikel
1365 Multicentre population-based dementia prevalence survey in Japan Ikejima, Chiaki
2013
9 4S p. P688
artikel
1366 Multicultural family detection of dementia Galvin, James
2013
9 4S p. P515
artikel
1367 Multimodal support vector machine for automated detection of functional and structural disconnection in Alzheimer's disease Dyrba, Martin
2013
9 4S p. P103
artikel
1368 Multiple daily cognitive measurements improve accuracy and increase statistical power, allowing smaller sample sizes for PoP trials in Alzheimer's disease Jaeger, Judith
2013
9 4S p. P887
artikel
1369 Multiple deaths of first-degree relatives during childhood predicts inflammation in late-life: A factor related to Alzheimer's disease risk Norton, Maria
2013
9 4S p. P489
artikel
1370 Multiplexed MRM assay verifies candidate Alzheimer's disease biomarkers in CSF Wildsmith, Kristin
2013
9 4S p. P210
artikel
1371 Multiscale permutation statistical complexity measure analysis of EEG in patients with mild Alzheimer's disease Morison, Gordon
2013
9 4S p. P279
artikel
1372 Multispecialty memory clinics harmonize diagnostic outcome Johannsen, Peter
2013
9 4S p. P735
artikel
1373 Multitarget strategy of traditional Chinese medicine in treatment of Alzheimer's disease Li, Lin
2013
9 4S p. P811
artikel
1374 Musical hallucinations in elderly patients: A brief report Martinelli, Jose
2013
9 4S p. P865-P866
artikel
1375 Music therapy, global affect and behavior in Alzheimer's disease: A meta-analytic perspective on outcomes and on music therapy methodologies Sepehry, Amir
2013
9 4S p. P665
artikel
1376 Music therapy with moderate Alzheimer's disease in a long-term care center Kwak, Kyungphil
2013
9 4S p. P880
artikel
1377 Mutations of TP53 C708T and C748A, oxidative DNA damage, and p53 and OGG1 protein levels in peripheral lymphocytes of the people with Alzheimer's disease Dorszewska, Jolanta
2013
9 4S p. P567
artikel
1378 Myelin integrity, cognitive function and hypertension in MCI and Alzheimer’s disease Lee, Athene
2013
9 4S p. P103
artikel
1379 Myelin integrity, cognitive function and hypertension in MCI and Alzheimer's disease Lee, Athene
2013
9 4S p. P275-P276
artikel
1380 Naming of transitive and intransitive verbs in Brazilians with Alzheimer's disease Beber, Bárbara
2013
9 4S p. P783-P784
artikel
1381 Naming Test of the Laboratory of Neuropsychological Investigations (TN-LIN): Preliminary psychometric properties Bertola, Laiss
2013
9 4S p. P460
artikel
1382 National planning for dementia-related supports and community care for adults with intellectual disabilities Service, Kathryn
2013
9 4S p. P473
artikel
1383 Neat, but not beta-amyloid–affinity-depleted, Baxter Immune Globulin® modulates behavior in transgenic mouse expressing Dutch beta-amyloid oligomers Knight, Elysse
2013
9 4S p. P885
artikel
1384 Needs and resources of Alzheimer's caregivers with reference to support services Baican, Eugen
2013
9 4S p. P472
artikel
1385 Needs assessment of people with memory disorders Bowen, Kate
2013
9 4S p. P471-P472
artikel
1386 Neprilysin activity in CSF is associated with CSF tau but neither with cerebral amyloid load nor CSF amyloid 1-42 in Alzheimer's disease Grimmer, Timo
2013
9 4S p. P859
artikel
1387 Network-based neurodegeneration in Alzheimer's disease: Evidence from resting-state fMRI Greicius, Michael
2013
9 4S p. P313
artikel
1388 Neuopathologic substrate of clinically evident, asymmetric, hippocampal atrophy in Alzheimer's disease Jicha, Gregory
2013
9 4S p. P389
artikel
1389 Neural cell death mechanisms induced by beta-amyloid and plausible therapeutic targets Hojin, Choi
2013
9 4S p. P711
artikel
1390 Neural correlates of lack of insight in mild cognitive impairment and Alzheimer's disease Bilgic, Basar
2013
9 4S p. P587
artikel
1391 Neural substrates of self-reference effect deficits in beta-amyloid–positive individuals with MCI and Alzheimer’s disease Gaubert, Malo
2013
9 4S p. P113-P114
artikel
1392 Neural substrates of self-reference effect deficits in beta-amyloid-positive people with MCI and Alzheimer's disease Gaubert, Malo
2013
9 4S p. P430
artikel
1393 Neuroanatomical correlates of the behavioral and psychiatric symptoms in Alzheimer's disease: A voxel-based morphometry study Hu, Xiaochen
2013
9 4S p. P376
artikel
1394 Neuroanatomical correlates of the behavioral and psychiatric symptoms in Alzheimer's disease: A voxel-based morphometry study Hu, Xiaochen
2013
9 4S p. P114
artikel
1395 Neuroanatomical specificity of psychosis, delusions and hallucinations in Alzheimer's disease Poulin, Stephane
2013
9 4S p. P747
artikel
1396 Neuroanatomical study of olfactory function in posterior cortical atrophy Witoonpanich, Pirada
2013
9 4S p. P373
artikel
1397 Neurodegenerative predictors of decline in MCI: Relationship to amyloid status Wolk, David
2013
9 4S p. P122-P123
artikel
1398 Neurodevelopment and aging in Down syndrome Lott, Ira
2013
9 4S p. P513
artikel
1399 Neurofibrillary tangles remain functionally integrated in cortical networks Kuchibhotla, Kishore
2013
9 4S p. P314
artikel
1400 Neuroinflammation in hAPPSL transgenic mice Löffler, Tina
2013
9 4S p. P161
artikel
1401 Neuronal activity regulates secretion of endogenous tau Pooler, Amy
2013
9 4S p. P314-P315
artikel
1402 Neuronal leptin resistance in Alzheimer's disease Bonda, David
2013
9 4S p. P574-P575
artikel
1403 Neuron-specific phosphorylation of APP: The roles in APP metabolism and function Suzuki, Toshiharu
2013
9 4S p. P532
artikel
1404 Neuropathological outcome of prospectively followed normal elderly brain bank volunteers Dugger, Brittany
2013
9 4S p. P336
artikel
1405 Neuroplastic effects induced by treatment with rivastigmine in MCI increase functional connectivity between the hippocampus and other limbic and cortical regions Venneri, Annalena
2013
9 4S p. P798-P799
artikel
1406 Neuroprotection by selective allosteric potentiator of M1 muscarinic receptor to restore reversal learning management in Alzheimer's disease Khatwal, Rizwan
2013
9 4S p. P840
artikel
1407 Neuroprotection by the synthetic enantiomers of the neurosteroids PREGS and DHEAS against beta-amyloid 25-35 peptide–induced toxicity Maurice, Tangui
2013
9 4S p. P507
artikel
1408 Neuroprotective effects of insulin against H2O2-induced oxidative stress in primary hippocampal cell culture Moosavi, Maryam
2013
9 4S p. P575
artikel
1409 Neuro-protective effects of pomegranate juice extracts on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridin (MPTP)–induced neurotoxicity in human neurons Essa, Mohamed
2013
9 4S p. P801
artikel
1410 Neuroprotective effects of pomegranate juice extracts on quinolinic acid–induced excitotoxicity in human neurons Essa, Mohamed
2013
9 4S p. P800-P801
artikel
1411 Neuroprotective effects of the selective androgen receptor modulator RAD140 in cultured neurons and kainate lesioned rats Jayaraman, Anusha
2013
9 4S p. P561
artikel
1412 Neuroprotective role of progesterone against 3-nitropropionic-acid–induced Huntington's disease-like symptoms in rats Kumar, Puneet
2013
9 4S p. P360
artikel
1413 Neuroprotective roles of oncoprotein MDMX in models of Alzheimer's disease Colacurcio, Daniel
2013
9 4S p. P193
artikel
1414 Neuropsychiatric and cognitive factors predict progression to mild cognitive impairment and dementia Donovan, Nancy
2013
9 4S p. P443
artikel
1415 Neuropsychiatric symptoms in community-dwelling Mexican-Americans: Results from the Hispanic EPESE Study Salazar, Ricardo
2013
9 4S p. P781
artikel
1416 Neuropsychiatric symptoms in dementia: Variation by care setting and gender Maxwell, Colleen
2013
9 4S p. P758
artikel
1417 Neuropsychological and neuroimaging differences between individuals with subjective cognitive decline recruited from memory clinic versus from the general population Perrotin, Audrey
2013
9 4S p. P218-P219
artikel
1418 Neuropsychological and neuroimaging differences between individuals with subjective cognitive decline recruited from memory clinic versus from the general population Perrotin, Audrey
2013
9 4S p. P824
artikel
1419 Neuropsychological assessment in geriatrics and its role in differential diagnosis Bocardi, Matheus
2013
9 4S p. P461-P462
artikel
1420 Neuropsychological characteristics of people with mild cognitive impairment with or without depression Jeong, Kwang Seok
2013
9 4S p. P725-P726
artikel
1421 Neuropsychological correlates of hippocampal atrophy in memory testing in nondemented elderly Vyhnalek, Martin
2013
9 4S p. P787-P788
artikel
1422 Neuropsychological evaluation and cortical thickness analysis of anasognosia in mild cognitive impairment and Alzheimer's disease Senturk, Gulben
2013
9 4S p. P592
artikel
1423 Neuropsychological predictors of autobiographical memory impairment in mild cognitive impairment (MCI) Buckley, Rachel
2013
9 4S p. P456
artikel
1424 Neuropsychological predictors of conversion in mild cognitive impairment Wakefield, Sarah
2013
9 4S p. P455
artikel
1425 Neuropsychological profile and neuropsychological markers of dementia in older people in Rio de Janeiro City, Brazil Charchat-Fichman, Helenice
2013
9 4S p. P453
artikel
1426 Neuropsychological profiles of asymptomatic adults with Down syndrome and evidence of amyloid deposition Handen, Benjamin
2013
9 4S p. P450-P451
artikel
1427 Neurotrophin signaling is altered in the retina of the P301S mutant human tau transgenic mouse Mazzaro, Nadia
2013
9 4S p. P168-P169
artikel
1428 Neutrophil-lymphocyte ratio in Alzheimer's disease: Data from the Australian Imaging Biomarker and Lifestyle study of ageing Rembach, Alan
2013
9 4S p. P203
artikel
1429 New cellular models for drug screening in Alzheimer's disease Holtzman, Jordan
2013
9 4S p. P890
artikel
1430 NIA genetics of Alzheimer's disease data storage site (NIAGADS): 2013 update Lin, Chiao-Feng
2013
9 4S p. P556
artikel
1431 Night home monitoring system improves caregiver health-related outcomes Rowe, Meredeth
2013
9 4S p. P516
artikel
1432 Night-to-night variability in sleep-disordered breathing and glucose hypometabolism in cognitively normal elderly Mantua, Janna
2013
9 4S p. P683
artikel
1433 β-N-Methylamino-L-alanine could be involved in Alzheimer's neurofibrillary pathology in amyotrophic lateral sclerosis–Parkinsonism dementia complex Arif, Mohammad
2013
9 4S p. P566
artikel
1434 Nobiletin-rich Citrus reticulata peels for Alzheimer's disease Seki, Takashi
2013
9 4S p. P281
artikel
1435 Non-beta-amyloid–related structural, metabolic and white matter fiber integrity changes in early-MCI Tosun, Duygu
2013
9 4S p. P19
artikel
1436 Non-beta-amyloid-related structural, metabolic and white matter fiber integrity changes in early MCI Tosun, Duygu
2013
9 4S p. P698-P699
artikel
1437 Non-3D pattern of copying the Necker cube as a risk of dementia among a nondemented population: Reanalysis from the Tajiri project Oonuma, Jiro
2013
9 4S p. P770
artikel
1438 Non-invasive detection of Alzheimer's disease beta-amyloid pathology in the lenses of people with Down syndrome Sarangi, Srikant
2013
9 4S p. P434
artikel
1439 Nonlinear registration of T1 MR imaging helps to support a diagnosis of a MAPT mutation when the phenotype is atypical Gordon, Elizabeth
2013
9 4S p. P35
artikel
1440 Nonlinear registration of T1 MR imaging helps to support a diagnosis of a MAPT mutation when the phenotype is atypical Gordon, Elizabeth
2013
9 4S p. P256
artikel
1441 Non-paraneoplastic limbic encephalitis associated with glutamic acid decarboxylase antibody Hanagasi, Hasmet
2013
9 4S p. P731
artikel
1442 Non- pharmacologic intervention in people with dementia in Brazil: An overview Abrisqueta-Gomez, Jacqueline
2013
9 4S p. P495-P496
artikel
1443 Normal healthy donors possess plasma IgG reactive to a neutralizing epitope for toxic and amyloid-seeding beta-amyloid oligomers Gibbs, Ebrima
2013
9 4S p. P810
artikel
1444 Normal pressure hydrocephalus: Treatable dementia, missed diagnosis—The Launceston Prevalence Study Razay, George
2013
9 4S p. P755
artikel
1445 Norms for total scores on the CERAD Neuropsychological Assessment Battery in an educationally diverse elderly population Han, Ji Young
2013
9 4S p. P794-P795
artikel
1446 Novel approach for the identification of small drug-like molecules that neutralize beta-amyloid 1-42 toxicity through direct interaction with oligomers Tepper, Armand
2013
9 4S p. P327
artikel
1447 Novel Ca2+-dependent interactions of presenilin 1 with synaptic proteins Kuzuya, Akira
2013
9 4S p. P520
artikel
1448 Novel CSF biomarkers associated with rates of brain atrophy in Alzheimer's disease Paterson, Ross
2013
9 4S p. P37
artikel
1449 Novel fusion protein bivalent for a general amyloid interaction motif reduces beta-amyloid aggregates in transgenic mice Levenson, Jonathan
2013
9 4S p. P810
artikel
1450 Novel multi-atlas automatic segmentation of medial temporal lobe volume change in Alzheimer's disease Kazemifar, Samaneh
2013
9 4S p. P602-P603
artikel
1451 Novel multi-atlas automatic segmentation of medial temporal lobe volume change in Alzheimer's disease Kazemifar, Samaneh
2013
9 4S p. P74-P75
artikel
1452 Novel rare variants associated with late-onset Alzheimer's disease candidate genes in Caribbean Hispanic families Vardarajan, Badri
2013
9 4S p. P551
artikel
1453 Novel small-molecule inhibitors of casein kinase 1 delta: A major new drug target for Alzheimer's disease Pike, Ian
2013
9 4S p. P717-P718
artikel
1454 Novel untranslated region-directed blockers of amyloid precursor protein translation for late Down syndrome and Alzheimer's disease therapy Rogers, Jack
2013
9 4S p. P855
artikel
1455 N-terminal modification of tau regulates its degradation Tanaka, Toshihisa
2013
9 4S p. P855
artikel
1456 Nurse perspectives and attitudes in residential care settings Sixsmith, Andrew
2013
9 4S p. P849
artikel
1457 Nutritional status and progression of dementia: The Cache County dementia progression study Sanders, Chelsea
2013
9 4S p. P735-P736
artikel
1458 Nutrition intervention in senior residences: Brain-healthy whole foods Lombardo, Nancy Emerson
2013
9 4S p. P803-P804
artikel
1459 Obesity and low testosterone interact to increase vulnerability to Alzheimer's disease pathogenesis Lee, Joo-Won
2013
9 4S p. P353
artikel
1460 Obesity-related FTO gene and longitudinal changes in brain volume during aging An, Yang
2013
9 4S p. P256-P257
artikel
1461 Obstructive sleep apnea and daytime resting EEG in mild Alzheimer's disease Johnsen, Kristinn
2013
9 4S p. P231
artikel
1462 Obstructive sleep apnea and neuropsychiatric symptoms in mild Alzheimer's disease Davidsdottir, Solveig
2013
9 4S p. P864-P865
artikel
1463 Office-based assessment of driving safety in older drivers with and without dementia Abularach, Linda
2013
9 4S p. P644
artikel
1464 O-GlcNAc-ase inhibitor improves the clinical conditions of Alzheimer's disease mice Borghgraef, Peter
2013
9 4S p. P509
artikel
1465 Older age at retirement is associated with decreased risk of dementia: Analysis of a health care insurance database of self-employed workers Dufouil, Carole
2013
9 4S p. P342-P343
artikel
1466 Olfactory identification as a potential marker of presymptomatic Alzheimer's disease Lafaille-Magnan, Marie-Elyse
2013
9 4S p. P208
artikel
1467 Olfactory learning and memory in the 5xFAD mouse model of Alzheimer's disease Roddick, Kyle
2013
9 4S p. P154
artikel
1468 Olfactory stress test (OST) performance in cognitively normal elders is associated with apolipoprotein E (APOE) genotype Schofield, Peter
2013
9 4S p. P202
artikel
1469 Oligomeric soluble beta-amyloid species induce calcium dyshomeostasis in the healthy living mouse brain Hudry, Eloise
2013
9 4S p. P126
artikel
1470 Omega-3 fish oil with purified eicosapentanenoic acid stimulates cerebral perfusion Pretorius, Harold
2013
9 4S p. P803
artikel
1471 One-year reduction of glucose metabolism in the olfactory tract in Alzheimer's disease Imabayashi, Etsuko
2013
9 4S p. P595-P596
artikel
1472 On the selection of cognitive and functional markers of brain volume and atrophy Yang, Eric
2013
9 4S p. P787
artikel
1473 Optimizing region-of-interest composites for capturing treatment effects on amyloid in clinical trials Tryputsen, Volha
2013
9 4S p. P287-P288
artikel
1474 Optimizing rehabilitation in dementia with acute illness: Project PERFECTED Fox, Chris
2013
9 4S p. P652
artikel
1475 Optogenetics to regulate synaptic connectivity in Alzheimer's disease Zahedi, Atena
2013
9 4S p. P703-P704
artikel
1476 Ordered subset analysis CNV association with Alzheimer's disease AAO phenotypes Szigeti, Kinga
2013
9 4S p. P176-P177
artikel
1477 Ordered values of subregional brain volumes improve the detection of disease progression in longitudinal studies of Alzheimer's disease: Data from ADNI Buck, Robert
2013
9 4S p. P76
artikel
1478 Oscillation-modifying drugs modify cognition in Alzheimer's mouse models Bibbig, Andrea
2013
9 4S p. P306
artikel
1479 Outcome of shunt surgery for normal pressure hydrocephalus in patients with and without comorbid Alzheimer's disease Klinge, Petra
2013
9 4S p. P850
artikel
1480 Outcomes of people with dementia and dysfagia who receive oral versus enteral nutrition Cintra, Marco Tulio
2013
9 4S p. P802-P803
artikel
1481 Overcoming the stigma of dementia Wortmann, Marc
2013
9 4S p. P547
artikel
1482 Overexpressing human wild- LRRK2 increases spatial recognition and working memory performance in mice Wang, Jun Ming
2013
9 4S p. P559
artikel
1483 Overview of the Korean Longitudinal Study on Cognitive Aging and Dementia Kim, Tae Hui
2013
9 4S p. P626-P627
artikel
1484 Palmitate induces transcriptional regulation of BACE1 and presenilin by STAT3 in neurons mediated by astrocytes Liu, Li
2013
9 4S p. P577
artikel
1485 Particular types of beta-amyloid oligomers are formed in Alzheimer's disease-like physiopathological conditions Ly, Myriam
2013
9 4S p. P196
artikel
1486 P300 as a potential biomarker for early detection of conversion from mild cognitive impairment to Alzheimer's dementia Parra, Mario
2013
9 4S p. P200
artikel
1487 Passive immunization against pyroglutamate-3 beta-amyloid decreases total plaque load in the absence of microhemorrhage and attenuates cognitive deficits in APP/PS1dE9 mice Frost, Jeffrey
2013
9 4S p. P508
artikel
1488 Pathogenic role of Pin1 in synaptic dysfunction in Alzheimer's disease Chow, Frances
2013
9 4S p. P711-P712
artikel
1489 Pathological and biochemical study of the nucleus accumbens in tangle-predominant dementia Kawakami, Ito
2013
9 4S p. P439
artikel
1490 Pathophysiological role of proteolytic cleavage of neuroligins Tomita, Taisuke
2013
9 4S p. P144
artikel
1491 Patients' self-reports on function and cognition in Alzheimer's disease are strongly influenced by their affective states: Principal component analysis of the CLIMAT scale Jacova, Claudia
2013
9 4S p. P650
artikel
1492 Patients with mild cognitive impairment exhibit gait disturbances when challenged cognitively Tseng, Benjamin
2013
9 4S p. P535
artikel
1493 Patterns of regional brain atrophy and amyloid deposition in Alzheimer's disease Duara, Ranjan
2013
9 4S p. P593
artikel
1494 Pentraxin inflammatory biomarkers and associations with risk of dementia and Alzheimer's disease in older adults Fitzpatrick, Annette
2013
9 4S p. P235
artikel
1495 People diagnosed with early-stage Alzheimer's disease show a slower increase in neuropsychiatric symptoms Hallikainen, Ilona
2013
9 4S p. P742
artikel
1496 People with dementia living in German shared-housing arrangements: Family engagement to promote quality of life Wolf-Ostermann, Karin
2013
9 4S p. P516
artikel
1497 Perceived physical health in family members of people with Alzheimer's disease McGee, Jocelyn
2013
9 4S p. P474
artikel
1498 Perception of Odor Episodic Memory (POEM) test as a candidate biomarker for early Alzheimer's disease Albers, Alefiya
2013
9 4S p. P199
artikel
1499 Perceptual binding of audiovisual speech information is disrupted at the preclinical stage of Alzheimer's disease Festa, Elena
2013
9 4S p. P452
artikel
1500 Performance-based assessment of everyday action in MCI Lawrence, Ibiyo
2013
9 4S p. P472-P473
artikel
1501 Performance of a genetics-based biomarker risk algorithm to support a clinical trial to delay onset of mild cognitive impairment due to Alzheimer's disease Lutz, Michael
2013
9 4S p. P860-P861
artikel
1502 Performance of different research criteria and cognitive tests to predict incident Alzheimer’s disease Wagner, Michael
2013
9 4S p. P537
artikel
1503 Performance of preliminary cut-points for progression from mild cognitive impairment to dementia of the Alzheimer's disease type using fully automated chemiluminescent beta-amyloid 42 and tau assays Simon, Adam
2013
9 4S p. P370
artikel
1504 Performance of Spanish-speaking community-dwelling elders in the U.S. on the Uniform Data Set (UDS) de Felipe, Jesus
2013
9 4S p. P621-P623
artikel
1505 Performance of the different proposed criteria for the diagnosis of mild cognitive impairment and Alzheimer's disease: Data from the Australian Imaging, Biomarkers and Lifestyle study of aging Chen, Yi-Hsuan
2013
9 4S p. P755-P756
artikel
1506 Performances on semantic memory tests in a consecutive memory clinic cohort Vogel, Asmus
2013
9 4S p. P789
artikel
1507 Performance testing of a fully automated, Chemiluminescent, beta-amyloid 42 assay Baburina, Irina
2013
9 4S p. P208
artikel
1508 Performance testing of a fully automated, Chemiluminescent, tau assay Kozo, Daniel
2013
9 4S p. P210-P211
artikel
1509 Perfusion and structural MRI correlates of brain amyloidosis in early MCI Tosun, Duygu
2013
9 4S p. P7-P8
artikel
1510 Perfusion and structural MRI correlates of brain amyloidosis in early MCI Tosun, Duygu
2013
9 4S p. P584-P585
artikel
1511 Periodontitis induced by bacterial infection exacerbates features of Alzheimer's disease in transgenic mice Ishida, Naoyuki
2013
9 4S p. P851
artikel
1512 Peripheral blood plasma protein levels are associated with Pittsburgh compound B binding in the brain Hwang, Kristy
2013
9 4S p. P257-P258
artikel
1513 Peripheral blood plasma protein levels are associated with Pittsburgh compound B-binding in the brain Hwang, Kristy
2013
9 4S p. P20-P21
artikel
1514 Peripheral inflammation increases PKR, GSK3β, and tau phosphorylation in wild-type mice Carret-Rebillat, Anne-Sophie
2013
9 4S p. P352
artikel
1515 Peripheral signatures of the clusterin-DKK neurotoxicity pathway as potential blood-based biomarkers Lovestone, Simon
2013
9 4S p. P860
artikel
1516 Person-specific change in home computer use predicts the development of mild cognitive impairment (MCI) Kaye, Jeffrey
2013
9 4S p. P445
artikel
1517 Perspective from aetna, a large, national insurer McDonough, Robert
2013
9 4S p. P826
artikel
1518 Perspective from the clinical research and manufacturing communities Feldman, Howard
2013
9 4S p. P826
artikel
1519 Perspective from wellpoint, a large, national insurer Whitney, John
2013
9 4S p. P826
artikel
1520 Perspectives on the benefits and harms of preclinical testing for Alzheimer's disease Arias, Jalayne
2013
9 4S p. P546
artikel
1521 PET imaging in APP/PS1 and APOE-ε4 animal models of Alzheimer's disease with F-18 quinoline Kulkarni, Padmakar
2013
9 4S p. P247
artikel
1522 PET imaging of cholinergic receptor binding in Alzheimer's disease, mild cognitive impairment and healthy elderly: Preliminary findings Sultzer, David
2013
9 4S p. P339
artikel
1523 PET imaging of cholinergic-receptor–binding in the healthy elderly and those with Alzheimer's disease or mild cognitive impairment: Preliminary findings Sultzer, David
2013
9 4S p. P94
artikel
1524 PET imaging using [18F]florbetaben in Alzheimer's disease mouse models Brendel, Matthias
2013
9 4S p. P29
artikel
1525 PET radioligand binding to translocator protein may mark conversion from mild cognitive impairment to Alzheimer's disease Kreisl, William
2013
9 4S p. P94-P95
artikel
1526 PET radioligand binding to translocator protein may mark conversion from mild cognitive impairment to Alzheimer's disease Kreisl, William
2013
9 4S p. P337
artikel
1527 PET with 18F-AV-45 (florbetapir) in posterior cortical atrophy Beaufils, Emilie
2013
9 4S p. P597-P598
artikel
1528 PGlu-beta-amyloid peptides, highly abundant in Alzheimer’s disease brain, are cytotoxic in vitro, in situ and in vivo Demuth, Hans
2013
9 4S p. P152
artikel
1529 P-glycoprotein (P-gp) efflux limits brain penetration of pioglitazone and stereoisomer of pioglitazone is a better brain penetrant Chang, Kai Lun
2013
9 4S p. P892
artikel
1530 Pharmacokinetics of BIIB037 in people with mild-to-moderate Alzheimer's disease (AD) participating in a phase 1 dose-escalation trial Ferrero, Jim
2013
9 4S p. P285
artikel
1531 Pharmacological blockade of TGF-beta signaling in peripheral macrophages mitigates Alzheimer's-like pathology in preclinical rodent models Weitz, Tara
2013
9 4S p. P167
artikel
1532 Pharmacological inhibition of the beta-amyloid and apolipoprotein E interaction ameliorates Alzheimer's pathology in APPSW/PS1dE9 / APOE-ε2-TR and APPSW/PS1dE9 / APOE-ε4-TR mice Pankiewicz, Joanna
2013
9 4S p. P152-P153
artikel
1533 Pharmacological treatment of Alzheimer's disease: Evidence, expectations and ambiguities Atri, Alireza
2013
9 4S p. P1
artikel
1534 Pharmacology of BAN2401: A monoclonal antibody selective for beta-amyloid protofibrils Swanson, Chad
2013
9 4S p. P809
artikel
1535 Phenolic compounds prevent beta-amyloid-protein oligomerization and synaptic dysfunction by site-specific binding Ono, Kenjiro
2013
9 4S p. P361
artikel
1536 Phospholipid levels in multiple brain regions in Alzheimer's disease: A 3D 31P-MRSI study Rijpma, Anne
2013
9 4S p. P95
artikel
1537 Phospholipid levels in multiple brain regions in Alzheimer's disease: A 3D 31P-MRSI study Rijpma, Anne
2013
9 4S p. P270-P271
artikel
1538 Physical activity and prevalence of cognitive impairment in community-dwelling very old individuals Chevallier-Collins, Claire
2013
9 4S p. P633
artikel
1539 Physical activity associated with lower prevalence of dementia Barcelos-Ferreira, Ricardo
2013
9 4S p. P623-P624
artikel
1540 Physical activity, independent functioning and emotional well-being in early-onset dementia Hooghiemstra, Astrid
2013
9 4S p. P526
artikel
1541 Physical activity is associated with improved executive function and processing speed: The LADIS Study Frederiksen, Kristian Steen
2013
9 4S p. P300-P301
artikel
1542 Physical morbidity in dementia Brodaty, Henry
2013
9 4S p. P310
artikel
1543 Physiological levels of beta-amyloid protein help maintain normal GSK and tau balance and improve memory Morley, John
2013
9 4S p. P186
artikel
1544 PIB-negative amnestic mild cognitive impairment related with low plasma apolipoprotein A1 level Choi, HyoJung
2013
9 4S p. P26-P27
artikel
1545 PIB-negative amnestic mild cognitive impairment related with low plasma apolipoprotein A1 level Choi, Hyo Jung
2013
9 4S p. P698
artikel
1546 Pilot project "MultiTANDEM": Extending the use of training programs to promote communication skills in the home care of persons with dementia Schall, Arthur
2013
9 4S p. P651
artikel
1547 Pilot trial of buddy-assisted exercise in people with mild cognitive impairment Sink, Kaycee
2013
9 4S p. P494
artikel
1548 Piperine enhances the neuroprotective effects of curcumin against mild traumatic brain injury–induced cognitive deficits: Behavioral, biochemical, mitochondrial and molecular correlates Rinwa, Puneet
2013
9 4S p. P158
artikel
1549 Pittsburgh compound B binding and MRI findings in nondemented hypertensive patients with cognitive concerns or mild cognitive impairment Smith, Eric
2013
9 4S p. P835
artikel
1550 Pittsburgh compound-B does not detect cotton wool plaques in PS-1 mutation carriers Ikonomovic, Milos
2013
9 4S p. P191
artikel
1551 Pituitary adenylate cyclise-activating polypeptide (PACAP) protects against beta-amyloid toxicity and potentiates mitochondrial function Han, Peng Cheng
2013
9 4S p. P355
artikel
1552 PK and PD of a nicotinic anticholinergic challenge with mecamylamine and comparison to scopolamine Baakman, Anne Catrien
2013
9 4S p. P805-P806
artikel
1553 Planning large-scale Alzheimer's disease questionnaire-aided studies (PLAQUES): Concordance of remote assessment methods with in-person diagnosis Okereke, Olivia
2013
9 4S p. P454
artikel
1554 Plaque-binding magnetic nanoparticles for early diagnosis of Alzheimer's disease by magnetic resonance imaging (MRI) Cheng, Kwok Kin
2013
9 4S p. P8
artikel
1555 Plasma beta-amyloid correlates with cognition and brain volumetrics in mild cognitive impairment Poljak, Anne
2013
9 4S p. P241
artikel
1556 Plasma beta-amyloid levels are significantly associated with a transition toward Alzheimer's disease as measured by cognitive decline and change in neocortical amyloid burden Rembach, Alan
2013
9 4S p. P681-P682
artikel
1557 Plasma beta-amyloid- oligomers and soluble tumor necrosis factor receptors are possible peripheral biomarkers for the early diagnosis of Alzheimer's disease Jia, Jianping
2013
9 4S p. P572
artikel
1558 Plasma clusterin levels and risk of dementia and Alzheimer's disease: The Framingham Heart Study Weinstein, Galit
2013
9 4S p. P681
artikel
1559 Plasma levels of lipocalin 2 and chitinase 3-like 1 protein in patients with amnestic mild cognitive impairment and Alzheimer's disease Kang, Kyunghun
2013
9 4S p. P860
artikel
1560 Plasma markers and cognitive decline in the ADAPT clinical trial Leoutsakos, Jeannie-Marie
2013
9 4S p. P234-P235
artikel
1561 Plasma protein profiling of mild cognitive impairment and Alzheimer's disease Muenchhoff, Julia
2013
9 4S p. P240-P241
artikel
1562 Policy, Systems, Care And Support Knapp, Martin
2013
9 4S p. P314
artikel
1563 Polymorphisms in PICALM, CLU and CR1 genes are associated with different cognitive endophenotypes in mild cognitive impairment Barabash, Ana
2013
9 4S p. P730-P731
artikel
1564 Poor prognostic factors in subcortical vascular dementia: A longitudinal cohort study of amyloid PET Imaging for subcortical vascular dementia Ye, Byoung Seok
2013
9 4S p. P726-P727
artikel
1565 Population-based analysis of late-onset Alzheimer's disease risk alleles identifies candidate gene-gene interactions Ebbert, Mark
2013
9 4S p. P551
artikel
1566 Population pharmacokinetic modeling of EVP-6124 following oral administration Kuan, Steve
2013
9 4S p. P660
artikel
1567 Possible involvements of beta-amyloid, insulin signaling and tau phosphorylation in the pathological interaction between Alzheimer's disease and diabetes Sato, Naoyuki
2013
9 4S p. P169-P170
artikel
1568 Possible synergistic effect of direct angiotensin II type 2 receptor stimulation by compound 21 with memantine on cognitive impairment in type 2 diabetic mouse Mogi, Masaki
2013
9 4S p. P355
artikel
1569 Posterior cingulate network adaptation in Alzheimer's disease Wang, Seqian
2013
9 4S p. P391
artikel
1570 Posterior cingulate network adaptation in Alzheimer's disease Parent, Maxime
2013
9 4S p. P75
artikel
1571 Postmortem study of hippocampus subfields and layers at 7T MR Yazdanie, Mohammad
2013
9 4S p. P103-P104
artikel
1572 Potential role of orexin in the pathogenesis of Alzheimer's disease Roh, Jee Hoon
2013
9 4S p. P521
artikel
1573 Practice effects and longitudinal cognitive change in normal aging versus incident mild cognitive impairment and dementia in the Mayo Clinic Study of Aging Machulda, Mary
2013
9 4S p. P793
artikel
1574 Preclinical characterization of a selective alpha-7 neuronal nicotinic acetylcholine receptor agonist ABT-126: A novel therapeutic agent for the treatment of cognitive impairment in Alzheimer's disease and schizophrenia Bitner, Robert
2013
9 4S p. P817-P818
artikel
1575 Preclinical characterization of RO4602522, a novel, selective and orally active monoamine oxidase type B inhibitor for the treatment of Alzheimer's disease Borroni, Edilio
2013
9 4S p. P818
artikel
1576 Precuneus volumes and cognitive tests in older adults Garcia, Angeles
2013
9 4S p. P795
artikel
1577 Predicitng Alzheimer’s disease–related cognition with cortical thickness correlations: A GLMNET approach Reid, Andrew
2013
9 4S p. P95-P96
artikel
1578 Predicting Alzheimer’s-related cognition with cortical thickness correlations: A GLMNET approach Reid, Andrew
2013
9 4S p. P147-P148
artikel
1579 Predicting beta-amyloid deposition and cognitive deficits in healthy adults: A multivariate analysis of neural processing during an FMRI face task Rieck, Jenny
2013
9 4S p. P27
artikel
1580 Predicting beta-amyloid deposition and cognitive deficits in healthy adults: A multivariate analysis of neural processing during an fMRI face task Rieck, Jenny
2013
9 4S p. P316
artikel
1581 Predicting cognitive function from clinical measures of mobility and health status: A L1-L2 regularized regression approach Bolandzadeh, Niousha
2013
9 4S p. P783
artikel
1582 Predicting dementia in Down syndrome: Study of a Portuguese cohort Breia, Paula
2013
9 4S p. P453-P454
artikel
1583 Predicting driving safety in people with dementia Yaari, Roy
2013
9 4S p. P744-P745
artikel
1584 Predicting in vivo BACE inhibitor efficacy: Are human iPS-derived neurons superior? Oborski, Christine
2013
9 4S p. P810-P811
artikel
1585 Predicting prodromal Alzheimer's disease in people with mild cognitive impairment using multicenter diffusion-tensor imaging data and machine learning algorithms Dyrba, Martin
2013
9 4S p. P426
artikel
1586 Predicting time to cognitive impairment using hippocampal volume Ercole, Lindsay
2013
9 4S p. P603-P604
artikel
1587 Prediction of functional decline and conversion from mild cognitive impairment with the telephone-administered Minnesota Cognitive Acuity Screen Ott, Brian
2013
9 4S p. P449
artikel
1588 Predictors of activities of daily living in older adults: The Frontal Systems Behavior Scale (FrSBe) and neuropsychological test performance Deutsch, Gayle
2013
9 4S p. P458
artikel
1589 Predictors of memory performance in a large, stratified, random population sample of older Americans: Clinical, demographic, lifestyle and genetic factors Ramanan, Vijay
2013
9 4S p. P679-P680
artikel
1590 Preeclampsia during pregnancy and Alzheimer's disease later in life Padbury, James
2013
9 4S p. P571
artikel
1591 Prefrontal hypometabolism in Alzheimer’s disease is caused by longitudinal amyloid accumulation in remote, functionally connected brain regions Klupp, Elisabeth
2013
9 4S p. P534
artikel
1592 Preliminary evaluation of a multicomponent cognitive intervention program for people with amnestic mild cognitive impairment and their family partners Lee, Kyoungmin
2013
9 4S p. P652-P653
artikel
1593 Preliminary findings from a 6-month randomized controlled trial of combined dual-task gait training and aerobic exercise in older adults with cognitive impairment but no dementia Gill, Dawn
2013
9 4S p. P480
artikel
1594 Preliminary report of the sleep effect of music therapy in Alzheimer's disease Li, Chien-Hsun
2013
9 4S p. P297-P298
artikel
1595 Presence of the APOE-ε4 gene in patients with mild cognitive impairment: First report in Costa Rica Roman, Norbel
2013
9 4S p. P371
artikel
1596 Presenilin 2 and mitofusin 2 physically interact and cooperate in endoplasmic reticulum-mitochondria tethering Filadi, Riccardo
2013
9 4S p. P575-P576
artikel
1597 Presenilin mutations impair mitochondrial dynamics in neurons Wang, Xinglong
2013
9 4S p. P349-P350
artikel
1598 Pre-symptomatic functional brain changes in PS1 E280A mutation carriers compared to other biomarkers: Pilot data from the Alzheimer's Prevention Initiative Biomarker project Fleisher, Adam
2013
9 4S p. P3
artikel
1599 Pre-symptomatic functional brain changes in PS1 E280A mutation carriers compared with other biomarkers: Pilot data from the Alzheimer's Prevention Initiative Biomarker project Fleisher, Adam
2013
9 4S p. P729
artikel
1600 Prevalence and growth of cerebral microhemorrhages in autosomal dominant Alzheimer's disease Blazey, Tyler
2013
9 4S p. P59-P60
artikel
1601 Prevalence and growth of cerebral microhemorrhages in autosomal dominant Alzheimer's disease Blazey, Tyler
2013
9 4S p. P130-P131
artikel
1602 Prevalence and impact of cumulative medical comorbidity in a rural, community-based sample of people with dementia LaPorte, Kenna
2013
9 4S p. P788
artikel
1603 Prevalence and predictors of mild cognitive impairment in old age: Results from the BABRI Study Ma, Chao
2013
9 4S p. P447-P449
artikel
1604 Prevalence and trends of cognitive impairment in U.S. older adults: The Third National Health and Nutrition Examination Survey Habtemariam, Daniel
2013
9 4S p. P611
artikel
1605 Prevalence of cognitive impairment based on the annual wellness visit Hara, Junko
2013
9 4S p. P119
artikel
1606 Prevalence of cognitive impairment in the annual wellness visit Hara, Junko
2013
9 4S p. P609
artikel
1607 Prevalence of depressive mood in frontotemporal dementia (FTD): A meta-analysis of studies from 2000 to present Sepehry, Amir
2013
9 4S p. P607
artikel
1608 Prevalence of executive dysfunction and associated factors in a community sample of Korean elderly Bae, Jae Nam
2013
9 4S p. P629-P630
artikel
1609 Prevalence of preclinical Alzheimer's disease among young adults: The Gipuzkoa Alzheimer Project study Martinez-Lage, Pablo
2013
9 4S p. P731
artikel
1610 Prevalence studies of dementia in mainland China, Hong Kong and Taiwan: A systematic review and meta-analysis Wu, Yu-Tzu
2013
9 4S p. P687-P688
artikel
1611 Preventing loss of independence through exercise (PLIE) Barnes, Deborah
2013
9 4S p. P476
artikel
1612 Preventive effects of cardiotonic pills on white matter damage and neuro-inflammation induced by chronic cerebral hypoperfusion in a rat model Jeon, WonKyung
2013
9 4S p. P162
artikel
1613 Primary progressive aphasia: Factors delaying diagnosis and care Jong, Frank Jan
2013
9 4S p. P119-P120
artikel
1614 Prion disease manifested as frontotemporal dementia in octogenarians Wu, Chuang-Kuo
2013
9 4S p. P437
artikel
1615 Prion protein mutation of 2 bp deletion in codon 178 causing a new type of HSAN type І Matsuzono, Kosuke
2013
9 4S p. P572
artikel
1616 PRISM registry: A novel tool to assess the prevalence of pseudobulbar affect symptoms in people with Alzheimer's disease Crumpacker, David
2013
9 4S p. P737
artikel
1617 Proactive dementia care: Year 2 experience Zamrini, Edward
2013
9 4S p. P527-P528
artikel
1618 Pro- and anti-inflammatory cytokines in Alzheimer's disease and vascular dementia Karadas, Omer
2013
9 4S p. P722
artikel
1619 Prodromal features of DLB/PDD McKeith, Ian
2013
9 4S p. P311
artikel
1620 Progression to dementia according to subtype of mild cognitive impairment (MCI) Fernandez, Cecilia
2013
9 4S p. P772
artikel
1621 Progressive memory loss with low amyloid burden in former professional American football players Rabinovici, Gil
2013
9 4S p. P875
artikel
1622 Progressive neurovascular disturbances in the cerebral cortex of Alzheimer's disease-model mice: Protection by atorvastatin and pitavastatin Kurata, Tomoko
2013
9 4S p. P502
artikel
1623 Project Learn MORE: Expanding service usage of individuals with early-stage Alzheimer's disease Galvin, James
2013
9 4S p. P615
artikel
1624 Prospective memory deficits in English- and Spanish-speaking patients with mild cognitive impairment (MCI) and PreMCI Loewenstein, David
2013
9 4S p. P323
artikel
1625 Protection against beta-amyloid–induced synaptic impairments via promotion of beta-amyloid oligomer aggregation by bis(heptyl)-cognitin Ian Chang,
2013
9 4S p. P299-P300
artikel
1626 Protective effect of Lycoris chejuensis on Alzheimer's disease experimental models in vitro and in vivo Kim, Joonki
2013
9 4S p. P506
artikel
1627 Protective effects of alkaloids from polyalthia glauca on beta-amyloid peptide (1-42)–induced neurotoxicity and caspase-3 in rat cortical cell cultures Thangnipon, Wipawan
2013
9 4S p. P299
artikel
1628 Protective factors in AD: Cognitive and brain reserve Stern, Yaakov
2013
9 4S p. P827
artikel
1629 Protective variant for rate of hippocampal volume loss identified by whole exome sequencing in APOE-ε3ε3 males with MCI Nho, Kwangsik
2013
9 4S p. P517-P518
artikel
1630 Protein biomarkers predicting longitudinal change in CSF beta-amyloid 42 in cognitively healthy controls Mattsson, Niklas
2013
9 4S p. P523
artikel
1631 Proteostasis: monitoring the health of the proteome in biology, aging and disease Morimoto, Richard
2013
9 4S p. P512
artikel
1632 Providing standardized labels of the EADC-ADNI Harmonized Hippocampal Protocol for automated algorithm training Boccardi, Marina
2013
9 4S p. P858
artikel
1633 Psychometric features of the ADAS-Cog: Identifying a potential cognition endpoint for prodromal Alzheimer's disease Hannesdottir, Kristin
2013
9 4S p. P461
artikel
1634 Psychometric properties of the ADAS-Cog from a Rasch measurement perspective Dowling, N. Maritza
2013
9 4S p. P124
artikel
1635 PTPA reduces phosphorylated PP2A level with upregulation of protein tyrosine phosphatase 1B Liu, Gong-Ping
2013
9 4S p. P716-P717
artikel
1636 Public health and epidemiology Ritchie, Karen
2013
9 4S p. P516
artikel
1637 Pulse pressure and atherosclerosis, arteriolosclerosis and cortical microinfarcts in individuals with clinical Alzheimer's disease Besser, Lilah
2013
9 4S p. P441
artikel
1638 Pyroglutamylated beta-amyloid is associated with hyperphosphorylated tau in human post-mortem brains Attems, Johannes
2013
9 4S p. P364
artikel
1639 Pyrroloquinoline quinine prevents aluminum-induced cognitive deficit in rats Zhou, Xingqin
2013
9 4S p. P158
artikel
1640 Qualification of a surrogate matrix-based absolute quantification method for beta-amyloid peptides in human CSF using 2D UPLC-SRM mass spectrometry Korecka, Magdalena
2013
9 4S p. P214-P215
artikel
1641 Qualitative assessment of self-identity in advanced dementia Batra, Sadhvi
2013
9 4S p. P643
artikel
1642 Quantification of higher order forms of beta-amyloid and total beta-amyloid peptides in CSF Oberoi, Pankaj
2013
9 4S p. P228
artikel
1643 Quantification of plasma p3-Alc[alpha]35 with C-terminal end–specific sELISA system Kaneko, Madoka
2013
9 4S p. P195
artikel
1644 Quantitative alteration of p3-Alc peptides in CSF of people with Alzheimer's disease Hata, Saori
2013
9 4S p. P199
artikel
1645 Quantitative analysis of gait disorders in people with Alzheimer's disease by using a portable gait rhythmograph Higuma, Maya
2013
9 4S p. P736
artikel
1646 Quantitative detection of oxidative DNA damage in brains of the triple transgenic Alzheimer's disease mouse model Akimoto, Yoriko
2013
9 4S p. P505
artikel
1647 Quantitative evaluation of anthropomorphic brain phantoms for standardization of amyloid PET SUVrs in alzheimer's Multicenter Therapeutic Trials Seibyl, John
2013
9 4S p. P594
artikel
1648 Quantitative label-free proteomics for discovery of biomarkers in cerebrospinal fluid: Assessment of technical and inter-individual variation Perrin, Richard
2013
9 4S p. P228
artikel
1649 Quantitative mass spectrometry assays for beta-amyloid, tau and phospho-tau in CSF Lahert, Emma
2013
9 4S p. P201
artikel
1650 Quantitative mass spectrometry (SRM/MRM) for amyloid peptides, tau protein and apolipoprotein E in human cerebrospinal fluid for Alzheimer's disease diagnosis Lehmann, Sylvain
2013
9 4S p. P212
artikel
1651 Quantitative mMR (PET/MRI) for Alzheimer’s disease detection Zhou, Yongxia
2013
9 4S p. P148
artikel
1652 Quantitative mMR (PET/MRI) for Alzheimer’s disease detection Zhou, Yongxia
2013
9 4S p. P96
artikel
1653 Quantitative regional validation of the rating scale for posterior cortical atrophy Möller, Christiane
2013
9 4S p. P376-P377
artikel
1654 Quantitative regional validation of the rating scale for posterior cortical atrophy Möller, Christiane
2013
9 4S p. P39
artikel
1655 Quantitative tractography of fibers crossing white matter hyperintensities Garcia, Angeles
2013
9 4S p. P722
artikel
1656 Quantitative tractography of fibers crossing white matter hyperintensities Garcia, Angeles
2013
9 4S p. P104
artikel
1657 Quick and accessible: The highly correlated Cognitive Self-Test (CST) Kuhn, Tarah
2013
9 4S p. P637-P638
artikel
1658 Randomized controlled trial of a telephone-delivered intervention (FITT-Caregiver) for dementia caregivers Tremont, Geoffrey
2013
9 4S p. P324-P325
artikel
1659 Rapid and progressive neurofibrillary tangle pathology in a novel in vivo model of tau propagation: Pattern of spread is determined by structural connectivity not spatial proximity Ahmed, Zeshan
2013
9 4S p. P141-P142
artikel
1660 Rapid Cognitive Screen: Sensitivity and specificity for cognitive dysfunction and predictive validity for poor health outcomes Malmstrom, Theodore
2013
9 4S p. P773
artikel
1661 Rapid visual categorization as a sensitive measure of early Alzheimer's disease Heindel, William
2013
9 4S p. P451-P452
artikel
1662 Rare variants from high-density exome genotyping in late-onset Alzheimer's disease Wang, Li-San
2013
9 4S p. P312
artikel
1663 Rare variants in APP and PSEN1 genes associated with extreme levels of beta-amyloid 42 and tau protein in cerebrospinal fluid Benitez, Bruno
2013
9 4S p. P680
artikel
1664 Rates of atrophy differ across pathologically defined subtypes of Alzheimer's disease: A longitudinal MRI study Whitwell, Jennifer
2013
9 4S p. P40
artikel
1665 Rates of atrophy differ across pathologically defined subtypes of Alzheimer's disease: A longitudinal MRI study Whitwell, Jennifer
2013
9 4S p. P600
artikel
1666 Rationale and design of an MRS study to explore the effects of the medical food Souvenaid® on brain metabolites in Alzheimer's disease Rijpma, Anne
2013
9 4S p. P801
artikel
1667 Reaction-time measures predict incident dementia over 4 years: The Sydney Memory and Ageing Study Kochan, Nicole
2013
9 4S p. P536
artikel
1668 Reasons to participate in Alzheimer's disease research: Varying perspectives of participants from the Wisconsin Registry for Alzheimer's Prevention Mueller, Kimberly
2013
9 4S p. P490
artikel
1669 Recovery of cognitive function through the promotion of chromatin remodeling in Alzheimer's disease models Tsai, Li-Hui
2013
9 4S p. P516
artikel
1670 Recruitment of people with amnestic mild cognitive impairment for an exercise study Hill, Candace
2013
9 4S p. P668
artikel
1671 Reduced amyloid deposition and greater hypometabolism in APOE-ε4-positive Alzheimer’s disease patients Lehmann, Manja
2013
9 4S p. P4-P5
artikel
1672 Reduced amyloid deposition and greater hypometabolism in people with Alzheimer's disease who are APOE-ε4–positive Lehmann, Manja
2013
9 4S p. P253
artikel
1673 Reduced CREB-regulated transcription coactivator-1 (CRTC1)–dependent transcription and memory loss in Alzheimer's disease transgenic mice Parra-Damas, Arnaldo
2013
9 4S p. P708
artikel
1674 Reduced heart rate variability is associated with worse cognitive function in elderly Mexican-Americans Al Hazzouri, Adina Zeki
2013
9 4S p. P135-P136
artikel
1675 Reduced sample size for preclinical amyloid-lowering therapeutic studies using optimal sampling of quantitative IHC data Grand'Maison, Marilyn
2013
9 4S p. P885
artikel
1676 Reduction in brain tissue volume with aging is associated with increased cerebrovascular resistance Liu, Jie
2013
9 4S p. P782-P783
artikel
1677 Reduction of tau oligomers by immunotherapy improves cognition in an Alzheimer’s disease mouse model Castillo-Carranza, Diana
2013
9 4S p. P325-P326
artikel
1678 Reductions in white-matter integrity in cognitively normal people with memory complaints Rhee, Hak Young
2013
9 4S p. P402
artikel
1679 Reflections of two parallel pathways between the hippocampus and neocortex in transient global amnesia: A cross-sectional study using DWI and SPECT Park, Young Ho
2013
9 4S p. P374
artikel
1680 Regional and whole-brain atrophy rates in autopsy-confirmed dementia with Lewy bodies and Alzheimer's disease Nedelska, Zuzana
2013
9 4S p. P40-P41
artikel
1681 Regional beta-amyloid deposition several years prior to beta-amyloid positivity Vlassenko, Andrei
2013
9 4S p. P431-P432
artikel
1682 Regional changes of subcortical structures in Alzheimer's disease: A three-year longitudinal study Cho, Hanna
2013
9 4S p. P599
artikel
1683 Regional differences in perivascular drainage of beta-amyloid from the aging mouse brain Hawkes, Cheryl
2013
9 4S p. P576-P577
artikel
1684 Regional distribution of brain fibrillar amyloid deposition as a function of CSF beta-amyloid 1-42 and biomarkers of neurodegeneration Cheewakriengkrai, Laksanun
2013
9 4S p. P830-P831
artikel
1685 Regional distribution of fibrillar amyloid deposition in the brain as a function of CSF beta-amyloid 1-42 and biomarkers of neurodegeneration Cheewakriengkrai, Laksanun
2013
9 4S p. P16-P17
artikel
1686 Regional FDG metabolism and instrumental activities of daily living across the spectrum of Alzheimer’s disease Roy, Kamolika
2013
9 4S p. P64-P65
artikel
1687 Regional white matter lesions and PIB retention in cognitively impaired elderly Silbert, Lisa
2013
9 4S p. P27
artikel
1688 Regional white matter lesions and Pittsburgh compound B retention in cognitively impaired elderly Silbert, Lisa
2013
9 4S p. P258-P259
artikel
1689 Region-specific associations of brain glucose metabolism with age and beta-amyloid deposition in normal aging Oh, Hwamee
2013
9 4S p. P393
artikel
1690 Region-specific associations of brain glucose metabolism with age and beta-amyloid in normal aging Oh, Hwamee
2013
9 4S p. P110
artikel
1691 Regiospecific loss of essential lipids sphingosine 1-phosphate and galactosylceramide early in Alzheimer's disease pathogenesis Don, Anthony
2013
9 4S p. P712-P713
artikel
1692 Registration of Alzheimer's disease in Taiwan, Hong Kong and Beijing Yang, Yuan-Han
2013
9 4S p. P614-P615
artikel
1693 Regular physical activity in a healthy elderly population is associated with lower peripheral iPLA2 activity Joaquim, Helena
2013
9 4S p. P244
artikel
1694 Regulation of TDP-43 on alternative splicing of tau exon 10 Gu, Jianlan
2013
9 4S p. P715
artikel
1695 Regulation of the high-affinity choline transporter activity and trafficking by its association with lipid rafts Cuddy, Leah
2013
9 4S p. P573
artikel
1696 Regulatory T cells delay disease progression in a murine model of Alzheimer's disease Toly-Ndour, Cécile
2013
9 4S p. P702-P703
artikel
1697 Relationship between anatomy and functional connectivity in default mode network in normal aging and mild Alzheimer's disease Hayata, Thaís
2013
9 4S p. P589-P590
artikel
1698 Relationship between BACE activity, inflammation and standard CSF biomarkers of Alzheimer's disease Alcolea, Daniel
2013
9 4S p. P199-P200
artikel
1699 Relationship between cortical thinning and cortical FDG hypometabolism in individuals with progressive MCI and Alzheimer's disease Wang, Lei
2013
9 4S p. P430-P431
artikel
1700 Relationship between cortical thinning and cortical FDG hypometabolism in individuals with progressive MCI and Alzheimer’s disease Alpert, Kathryn
2013
9 4S p. P65-P67
artikel
1701 Relationship between marital and parental status and risk of dementia and Alzheimer's disease Sundström, Anna
2013
9 4S p. P631
artikel
1702 Relationship of cognitive reserve and APOE status to clinical symptom onset of mild cognitive impairment: The BIOCARD Cohort Soldan, Anja
2013
9 4S p. P134
artikel
1703 Relationship of microglial activation measured by [11C]PBR28 PET, atrophy on MRI and plasma biomarkers in individuals with and at-risk for Alzheimer's disease Risacher, Shannon
2013
9 4S p. P272-P273
artikel
1704 Relationship of microglial activation measured by [11C]PBR28 PET, atrophy on MRI and plasma biomarkers in individuals with and at risk for Alzheimer's disease Risacher, Shannon
2013
9 4S p. P63
artikel
1705 Relationships among biomarkers in early-stage Alzheimer's disease (AD): Findings in cognitively normal adults from the Alzheimer's Disease Neuroimaging Initiative (ADNI) Haight, Thaddeus
2013
9 4S p. P832
artikel
1706 Relationships between cognitive activity, Alzheimer's disease pathological biomarkers and cognitive functioning in normal older adults Wirth, Miranka
2013
9 4S p. P393-P394
artikel
1707 Reliability and validity of the Korean version of the Frontal Behavioral Inventory in people with dementia Kim, Eun Joo
2013
9 4S p. P790
artikel
1708 Religion and cognitive decline in the older U.S. population Lang, Iain
2013
9 4S p. P615-P616
artikel
1709 Religious dogmatism in neurodegenerative disease Block, Nikolas
2013
9 4S p. P750
artikel
1710 Removal of blood beta-amyloid might reduce brain beta-amyloid deposition based on the study of hemodialysis patients: Extracorporeal beta-amyloid removal system (EARS) for Alzheimer's disease therapy Kitaguchi, Nobuya
2013
9 4S p. P807
artikel
1711 Repeat testing with the Audio Recorded Cognitive Screen (ARCS) in an outpatient clinic Schofield, Peter
2013
9 4S p. P463
artikel
1712 Reproducibility of a fully automated, chemiluminescent, beta-amyloid 42 assay Jackson, Shari
2013
9 4S p. P210
artikel
1713 Reproducibility of a fully automated chemiluminescent tau assay Tweedie, Anne
2013
9 4S p. P738
artikel
1714 Reproducibility of intracranial and hippocampal volume quantification at 1.5T and 3T MRI: Application to ADNI I Roche, Florent
2013
9 4S p. P104-P105
artikel
1715 Reproducibility of intracranial and hippocampal volume quantification at 1.5T and 3T MRI: Application to ADNI I Roche, Florent
2013
9 4S p. P271
artikel
1716 Required features of a fluorine-19 MRI probe for amyloid detection in the brain Yanagisawa, Daijiro
2013
9 4S p. P247
artikel
1717 Rescue of Behavioral and neurodegenerative phenotypes in symptomatic tau KO mice: Therapeutic implications for neurodegenerative diseases Lei, Peng
2013
9 4S p. P848
artikel
1718 Rescue of MK-801–induced learning deficits in an incremental repeated acquisition task using an α5 GABA(A) inverse agonist Rudy, Carolyn
2013
9 4S p. P158-P159
artikel
1719 Research to practice: The TTAP Method® a new psychology of art, brain and cognition Levine-Madori, Linda
2013
9 4S p. P293
artikel
1720 Response to an acute pharmacological challenge with galantamine as a predictor for responsiveness to long-term treatment Baakman, Anne Catrien
2013
9 4S p. P659-P660
artikel
1721 Resting-state connectivity impairment in a rat model of Alzheimer's disease Parent, Maxime
2013
9 4S p. P499-P500
artikel
1722 Resting-state connectivity impairment in a rat model of Alzheimer's disease Parent, Maxime
2013
9 4S p. P29-P30
artikel
1723 Resting state executive control network adaptations in amnestic mild cognitive impairment Wu, Liyong
2013
9 4S p. P420-P422
artikel
1724 Resting state functional connectivity in autosomal dominant and sporadic Alzheimer's disease Thomas, Jewell
2013
9 4S p. P252-P253
artikel
1725 Resting state functional connectivity in autosomal dominant and sporadic Alzheimer’s disease Thomas, Jewell
2013
9 4S p. P105
artikel
1726 Results from the Israel Diabetes and Cognitive Decline Study: Genes and glycemic control Beeri, Michal Schnaider
2013
9 4S p. P618-P619
artikel
1727 Results of the GAP 160701 study: A phase 3 clinical trial of intravenous immunoglobulin for mild-to-moderate Alzheimer's disease Relkin, Norman
2013
9 4S p. P530
artikel
1728 Retained lexis in people with Alzheimer's disease Alegria, Renne
2013
9 4S p. P486-P487
artikel
1729 Retinal changes in amnestic mild cognitive impairment Pillai, Jagan
2013
9 4S p. P214
artikel
1730 Retinal vessel calibers associate differentially with grey matter and white matter atrophy on MRI Ikram, Mohammad
2013
9 4S p. P109
artikel
1731 Retinal vessel calibers associate differentially with grey matter and white matter atrophy on MRI Ikram, Mohammad
2013
9 4S p. P545
artikel
1732 Reversal of synaptic plasticity and spatial memory deficits in APP/PS1 mice by suppressing protein kinase GCN2 Ma, Tao
2013
9 4S p. P519-P520
artikel
1733 Revisiting protein kinases as CNS targets: Attenuation of synaptic dysfunction Watterson, D. Martin
2013
9 4S p. P818-P819
artikel
1734 Risk and protective factors for dementia in people 85 and older Wallin, Karin
2013
9 4S p. P837-P838
artikel
1735 Risk factors for dementia in life course approach Glymour, M. Maria
2013
9 4S p. P511
artikel
1736 Risk factors of family caregiver burden: Results from a large community dataset Park, Myonghwa
2013
9 4S p. P483-P484
artikel
1737 Risk factors of incident dementia in Korean elderly: Community-based cohort study Seo, Hyun-Ju
2013
9 4S p. P629
artikel
1738 Risk of mortality associated with atypical antipsychotics in people with dementia: A prospective cohort study Arai, Heii
2013
9 4S p. P306
artikel
1739 Risk score for the prediction of Alzheimer's disease progression in people with amnestic mild cognitive impairment: A multicenter, clinic-based longitudinal study Ye, Byoung Seok
2013
9 4S p. P769
artikel
1740 RNA-sequencing evaluation of fresh frozen and formaldehyde-fixed prefrontal cortex brain tissue for the study of Alzheimer's disease Dumitriu, Alexandra
2013
9 4S p. P177
artikel
1741 RNA transcription and editing in Alzheimer’s disease Humphries, Crystal
2013
9 4S p. P829-P830
artikel
1742 RNS60, a novel therapeutic containing charge-stabilized oxygen nanobubbles, demonstrates efficacy in a transgenic mouse model of Alzheimer's disease Modi, Khushbu
2013
9 4S p. P702
artikel
1743 Robotherapy in dementia: Pilot study Valentí-Soler, Meritxell
2013
9 4S p. P296-P297
artikel
1744 Role of depression in chronic pain among people with Alzheimer's disease Papaliagkas, Vasileios
2013
9 4S p. P786
artikel
1745 Role of genetic variation on longitudinal imaging measures of Alzheimer's disease in the ADNI Cohort Honea, Robyn
2013
9 4S p. P257
artikel
1746 Role of mitochondria-specific antioxidants and their derivatives in drug discovery and development for Alzheimer's disease Aliev, Gjumrakch
2013
9 4S p. P562-P563
artikel
1747 Role of PKR in a mouse model of neuronal degeneration linked to oxidative stress Mouton-Liger, François
2013
9 4S p. P498
artikel
1748 Rotigotine improves executive functions in patients with vascular dementia Silvestri, Antonello
2013
9 4S p. P120
artikel
1749 Safety and tolerability of avagacestat (BMS-708163) in people with predementia Alzheimer's disease: Association with nonmelanoma skin cancer Preston, Jeanette
2013
9 4S p. P282-P283
artikel
1750 Safety, pharmacokinetics and pharmacodynamics of PQ912, the first glutaminyl cyclase (QC) inhibitor to treat Alzheimer's disease, in healthy elderly Black, Ronald
2013
9 4S p. P280
artikel
1751 Safety, tolerability and immunogenicity of an immunotherapeutic vaccine (vanutide cridificar [ACC-001]) and the QS-21 adjuvant in Japanese individuals with mild-to-moderate Alzheimer's disease: A phase IIa, multicenter, randomized, adjuvant and placebo clinical trial Arai, Heii
2013
9 4S p. P282
artikel
1752 Same-day and two-week test–retest reproducibility of automated hippocampal volumes using structural MRI Leung, Kelvin
2013
9 4S p. P91-P92
artikel
1753 Same-day and 2-week test-retest reproducibility of automated hippocampal volumes using structural MRI Leung, Kelvin
2013
9 4S p. P415-P416
artikel
1754 SAR228810: An antiprotofibrillar beta-amyloid antibody designed to reduce risk of amyloid-related imaging abnormalities (ARIA) Pradier, Laurent
2013
9 4S p. P808-P809
artikel
1755 Satisfaction of elderly research volunteers with home-based clinical trial participation Sano, Mary
2013
9 4S p. P781
artikel
1756 Saxagliptin: A dipeptidyl peptidase-4 inhibitor ameliorates streptozotocin-induced Alzheimer's disease Kosaraju, Jayasankar
2013
9 4S p. P501
artikel
1757 Scanner resolution effects on Pittsburgh compound B and florbetapir quantitative measurements Klein, Gregory
2013
9 4S p. P266-P267
artikel
1758 Scientific validity and ethics of freely accessible online tests for Alzheimer’s disease Robillard, Julie
2013
9 4S p. P341-P342
artikel
1759 Screening for small molecules to enhance differentiation and neurite outgrowth in human iPSC-derived neurons: Opportunities for Alzheimer's disease and other neurodegenerative diseases Pan, Wensheng
2013
9 4S p. P360
artikel
1760 Screening question on spatial navigation reflects performance in the real-space human analogue of the Morris Water Maze in people at risk of Alzheimer's disease Mokrišová, Ivana
2013
9 4S p. P610-P611
artikel
1761 Screening utility of the Montreal Cognitive Assessment compared with the Mini-Mental State Exam and Mattis Dementia Rating Scale Muniz, Martha
2013
9 4S p. P791-P792
artikel
1762 Secretase-dependent APP-CTF accumulation influences differentially axodendritic development and associated signalling Deyts, Carole
2013
9 4S p. P188
artikel
1763 Seeded beta-amyloid in long-term hippocampal slice cultures Novotny, Renata
2013
9 4S p. P434-P435
artikel
1764 Seeded initiation and spread of aggregated beta-amyloid Walker, Lary
2013
9 4S p. P673
artikel
1765 See me as a person: A behavioral approach promoting life-long wellbeing Karsten, Margo
2013
9 4S p. P477-P478
artikel
1766 Segmentation analyses for assessing cortical SUVr in Alzheimer's disease using the novel PET amyloid tracer 18F-NAV4694 Seibyl, John
2013
9 4S p. P418
artikel
1767 Selecting reliable cognitive complaint questions for use among older adults Gifford, Katherine
2013
9 4S p. P767
artikel
1768 Selection and characterization of tau-binding D-enantiomeric peptides for therapeutic applications in neurodegenerative diseases Funke, Susanne
2013
9 4S p. P330
artikel
1769 Selective drug inhibition of rho kinase II (ROCK2) reduces beta-amyloid production in the brain Herskowitz, Jeremy
2013
9 4S p. P153
artikel
1770 Self and proxy ratings of patient-reported outcomes: Impact of cognitive status Soleimani, laili
2013
9 4S p. P491
artikel
1771 Self-rating anxiety scales in people with Alzheimer's disease visiting a neurology practice Townsend, Lisa
2013
9 4S p. P785
artikel
1772 Self-reported activity in older adults: Challenges and innovations Wild, Katherine
2013
9 4S p. P342
artikel
1773 Self-reported head injury and risk of cognitive impairment and Alzheimer's-type pathology in a longitudinal Alzheimer’s disease center cohort Abner, Erin
2013
9 4S p. P838
artikel
1774 Self-reported memory decline predicts mild cognitive impairment and dementia Kryscio, Richard
2013
9 4S p. P771
artikel
1775 Self-reported quality of life after retirement and cognitive function: Data from the Nurses' Health Study Kang, Jae
2013
9 4S p. P633
artikel
1776 Self-reported versus informant-based cognitive complaints: Relation of E-Cog scores to imaging biomarkers and clinical status in ADNI-2 Risacher, Shannon
2013
9 4S p. P60-P62
artikel
1777 Self- versus informant-based cognitive complaints: Relation of E-Cog scores to imaging, biomarkers and clinical Status in ADNI-2 Risacher, Shannon
2013
9 4S p. P429
artikel
1778 Semantic dementia: A case report Schultz, Rodrigo
2013
9 4S p. P786-P787
artikel
1779 Semantic memory and its relationship to episodic memory and amyloid burden in cognitively normal (CN) older adults and those with mild cognitive impairment (MCI) Papp, Kate
2013
9 4S p. P457-P458
artikel
1780 Separation of drug effect from placebo control in Alzheimer's disease trials: Improving the chances Miller, David
2013
9 4S p. P653
artikel
1781 Serum antibodies against tobacco mosaic virus and human protein TOMM40L Liu, Ruolan
2013
9 4S p. P363
artikel
1782 Serum brain-derived neurotrophic factor and risk of dementia: The Framingham Heart Study Weinstein, Galit
2013
9 4S p. P232
artikel
1783 Serum brain-derived neurotrophic factor in people with untreated Alzheimer's disease: Correlation with mood and cognition Piñol-Ripoll, Gerard
2013
9 4S p. P569
artikel
1784 Serum 25-hydroxyvitamin D is associated with cognitive executive function in Dutch prefrail and frail elderly Brouwer-Brolsma, Elske
2013
9 4S p. P883
artikel
1785 Serum levels of albumin-beta-amyloid complexes are usable biomarkers for Alzheimer's disease Yamamoto, Keiichi
2013
9 4S p. P233-P234
artikel
1786 Serum progranulin is affected by variability in pre-analytical and biobanking procedures Teunissen, Charlotte
2013
9 4S p. P242-P243
artikel
1787 Serum TNF alpha levels elevated in early and late-onset Alzheimer's disease but not in mild cognitive impairment Alaylioglu, Merve
2013
9 4S p. P239-P240
artikel
1788 Serum trace metal levels in Alzheimer's disease and normal control groups Lee, Dong-Woo
2013
9 4S p. P244-P245
artikel
1789 Severe sleep-disordered breathing is associated with cognitive performance in the general population: Results of the Heinz Nixdorf Recall study Dlugaj, Martha
2013
9 4S p. P609
artikel
1790 Sevoflurane may not exacerbate the eye phenotype in Alzheimer's disease-transgenic Drosophila Chen, Chia-Wen
2013
9 4S p. P708
artikel
1791 Short-term efficacy for acute electroconvulsive therapy for agitation and aggression in dementia Forester, Brent
2013
9 4S p. P881
artikel
1792 Short-term predictors of clinical progression in the Harvard Aging Brain Study Mormino, Elizabeth
2013
9 4S p. P397-P398
artikel
1793 Short-term predictors of clinical progression in the Harvard Aging Brain Study Mormino, Elizabeth
2013
9 4S p. P28
artikel
1794 Should Ms. Daisy be driving? The assessment and counseling of demented drivers Carr, David
2013
9 4S p. P2
artikel
1795 Sickness behaviour in dementia: The Southampton Sickness Behaviour Scale Butchart, Joe
2013
9 4S p. P756
artikel
1796 Significance of cerebellar activity in the attention network in MCI Li, Kuncheng
2013
9 4S p. P417-P418
artikel
1797 Significant longitudinal change in neostriatal volume in premanifest and manifest Huntington's disease: The IMAGE-HD study Wilkes, Fiona
2013
9 4S p. P595
artikel
1798 Significant risk of dementia in shunt-responsive idiopathic normal pressure hydrocephalus Leinonen, Ville
2013
9 4S p. P748
artikel
1799 Similar maximal educational attainment in people with dementia: Association with pathologically diagnosed frontotemporal lobar degeneration, Alzheimer's disease and Lewy body disease? Bruns, Marla
2013
9 4S p. P631
artikel
1800 Simultaneous changes in cognition and physical frailty and the association of neuropathology Yu, Lei
2013
9 4S p. P344
artikel
1801 Simultaneous measurement of blood-CSF and blood-brain barrier permeability: A pilot 7T dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) study Anderson, Valerie
2013
9 4S p. P260-P261
artikel
1802 Simultaneous PET-MRI in the characterization of dementia Moodley, Kuven
2013
9 4S p. P385-P386
artikel
1803 Since efficacious treatments for Alzheimer's disease (AD) became available, AD diagnosis has been made at earlier stages and memory clinics have been sought by less impaired individuals Grimmer, Timo
2013
9 4S p. P771-P772
artikel
1804 Singapore experience with cognitive screening Lim, Lay Hoon
2013
9 4S p. P770
artikel
1805 Single APP locus knock-in mouse models of Alzheimer's disease: Distinguishing facts from artifacts Saido, Takaomi
2013
9 4S p. P846-P847
artikel
1806 SIST-M-IR activities of daily living items that best discriminate the clinically normal elderly from those with mild cognitive impairment Zoller, Amy
2013
9 4S p. P779
artikel
1807 Six-year prospective evaluation of cognitive performance in elderly people with bipolar disorder Coelho, Leticia
2013
9 4S p. P780
artikel
1808 Sleep disturbance predicts incident dementia and mortality Sterniczuk, Roxanne
2013
9 4S p. P541
artikel
1809 Small-molecule lead identification for inhibition of tau oligomer formation Moe, James
2013
9 4S p. P891
artikel
1810 Small molecules targeting Rho GTPase signaling altered in Alzheimer's disease Lu, Qun
2013
9 4S p. P893-P894
artikel
1811 Soluble APPβ in blood differentiates Alzheimer's disease from healthy aging and non-Alzheimer's dementia Perneczky, Robert
2013
9 4S p. P240
artikel
1812 Soluble BACE activity and sAPPβ levels do not differentiate Alzheimer's disease and age-matched control cerebrospinal fluid in the ADNI-1 cohort Savage, Mary
2013
9 4S p. P201
artikel
1813 SORL1 is genetically associated with late-onset Alzheimer's disease in Japanese, Koreans and Caucasians Kuwano, Ryozo
2013
9 4S p. P693-P694
artikel
1814 Sowing the seeds of hope: The potential to slow disease now and prevent dementia in the future Sperling, Reisa
2013
9 4S p. P1
artikel
1815 Space-like radiation causes accelerated cognitive impairment and increased Alzheimer's-like pathology in CRND8 APP transgenic mice Wang, Xinglong
2013
9 4S p. P191
artikel
1816 Sparse Bayesian learning for identifying the neuroanatomical basis of cognitive impairment in Alzheimer’s disease Wan, Jing
2013
9 4S p. P62-P63
artikel
1817 Sparse Bayesian learning for identifying the neuroanatomical basis of cognitive impairment in Alzheimer's disease Wan, Jing
2013
9 4S p. P578-P579
artikel
1818 SPCT findings in early-onset Alzheimer's disease compared with late-onset Alzheimer's Katayama, Sadao
2013
9 4S p. P872
artikel
1819 Specific cerebellar grey matter volume loss is predictive for episodic memory retrieval deficits in early Alzheimer's disease Jacobs, Heidi
2013
9 4S p. P115
artikel
1820 Specific inhibitory mechanisms for beta-amyloid 42 aggregation by flavonoids Sato, Mizuho
2013
9 4S p. P183
artikel
1821 Specific targeting of tau oligomeric seeds by passive immunization Castillo-Carranza, Diana
2013
9 4S p. P330
artikel
1822 Spectrum of NOTCH3 mutations in Korean patients with clinically suspicious cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy Yoon, Cindy
2013
9 4S p. P730
artikel
1823 Spirituality as a resource in mild Alzheimer's disease McGee, Jocelyn
2013
9 4S p. P644
artikel
1824 Spiritual struggle, mood and behavior in people with mild Alzheimer's disease McGee, Jocelyn
2013
9 4S p. P645
artikel
1825 Spontaneous use and incidental learning of an effective memory strategy in mild cognitive impairment Woo, Ellen
2013
9 4S p. P444-P445
artikel
1826 SREBP-2-mediated cholesterol accumulation regulates beta-amyloid–induced autophagy in APP/PS1/SREBP-2 mice Barbero-Camps, Elisabeth
2013
9 4S p. P194-P195
artikel
1827 Stability performance of a fully automated, chemiluminescent, beta-amyloid 42 assay Ackles, Karen
2013
9 4S p. P200
artikel
1828 Stability performance of a fully automated, chemiluminescent tau assay for the VITROS® immunodiagnostic systems with cerebrospinal fluid over a 29-week study DiMagno, Lisa
2013
9 4S p. P765
artikel
1829 Staging of microstructural white matter damage in early Alzheimer's disease Zhuang, Lin
2013
9 4S p. P582
artikel
1830 Stalled blood flow in cortical capillaries, caused by recurrent plugging by leukocytes, contributes to brain blood flow reductions in mouse models of Alzheimer's disease Nishimura, Nozomi
2013
9 4S p. P164-P165
artikel
1831 Standardization of beta-amyloid reference peptides Tzaferis, John
2013
9 4S p. P813
artikel
1832 Standardized statistical framework for comparison of biomarkers Harvey, Danielle
2013
9 4S p. P676-P677
artikel
1833 Standards for Alzheimer's Disease Research in Blood Biomarkers (STAR-B) O'Bryant, Sid
2013
9 4S p. P675-P676
artikel
1834 Statin exposure and structural integrity measures in the brain of older adults in the Health ABC Study Nadkarni, Neelesh
2013
9 4S p. P811
artikel
1835 Stimulation of skin by ablution (ritual washing) prevents Alzheimer's in humans: An original study Ashraf, Hashim
2013
9 4S p. P658
artikel
1836 sTNF-R1 as a biomarker of Alzheimer's disease varies by APOE-ε4 status Edwards, Melissa
2013
9 4S p. P236
artikel
1837 Strategic brain areas for cognitive decline in subcortical vascular cognitive impairment: A diffusion tensor imaging and PET study Kim, Min-Jeong
2013
9 4S p. P106
artikel
1838 Strategic brain areas for cognitive decline in subcortical vascular cognitive impairment: A diffusion-tensor imaging and PET study Kim, Min-Jeong
2013
9 4S p. P583-P584
artikel
1839 Stratification by baseline age of mild cognitive impairment (MCI) and conversion to different types of dementia Fernandez, Cecilia
2013
9 4S p. P772-P773
artikel
1840 Stress and associated risk factors in elderly adults: Results from the Einstein Aging Study Ezzati, Ali
2013
9 4S p. P623
artikel
1841 Stress and risk of amnestic mild cognitive impairment: Results from the Einstein Aging Study Katz, Mindy
2013
9 4S p. P611-P612
artikel
1842 Stress triggers tau aggregation through dysregulation of the chaperone-mediated degradation machinery and promotion of apoptosis Sotiropoulos, Ioannis
2013
9 4S p. P718
artikel
1843 Strong compliance with electronic observer-reported outcome reporting in a multinational Alzheimer's disease clinical trial Gary, Sarah Tressel
2013
9 4S p. P663-P664
artikel
1844 Structural and functional connectivity in the logopenic variant of primary progressive aphasia and a comparison to dementia of the Alzheimer's type Whitwell, Jennifer
2013
9 4S p. P833
artikel
1845 Structural and functional connectivity in the logopenic variant of primary progressive aphasia and a comparison with dementia of the Alzheimer's type Whitwell, Jennifer
2013
9 4S p. P40
artikel
1846 Structural brain changes after robot-assisted cognitive training in the elderly: A single-blind randomized controlled trial Kim, Geon Ha
2013
9 4S p. P476-P477
artikel
1847 Structural changes of the corpus callosum predicts severe cognitive decline and dementia: A longitudinal 7-year study Sylvaine, Artero
2013
9 4S p. P411
artikel
1848 Structural connectivity in three mouse models of Alzheimer’s disease: An in vivo diffusion tensor imaging study Marizzoni, Moira
2013
9 4S p. P683-P684
artikel
1849 Structural connectivity in three mouse models of Alzheimer’s disease: An in vivo diffusion tensor imaging study Marizzoni, Moira
2013
9 4S p. P30-P31
artikel
1850 Structural covariance among synaptically connected, tau-susceptible subfields of the medial temporal lobe Kerchner, Geoffrey
2013
9 4S p. P833-P834
artikel
1851 Structural covariance among synaptically connected, tau-susceptible subfields of the medial temporal lobe Kerchner, Geoffrey
2013
9 4S p. P63-P64
artikel
1852 Structural MRI abnormalities in people with chronic kidney disease Vemuri, Prashanthi
2013
9 4S p. P386-P387
artikel
1853 Structural MRI measures in Alzheimer's disease and effects of ethnicity Zhang, Linda
2013
9 4S p. P585
artikel
1854 Structural MRI measures in Alzheimer's disease and effects of ethnicity Zhang, Linda
2013
9 4S p. P114-P115
artikel
1855 Study of rare variants in Alzheimer's disease Sims, Rebecca
2013
9 4S p. P312
artikel
1856 Subcortical ischemic disease is associated with regionally specific cortical atrophy distinct from that seen in Alzheimer's disease Blacker, Deborah
2013
9 4S p. P387
artikel
1857 Subjective cognition and ‘neuroticism,' but not depressive symptoms, are associated with beta-amyloid deposition in cognitively normal elderly Snitz, Beth
2013
9 4S p. P75
artikel
1858 Subjective cognition and neuroticism, but not depressive symptoms, are associated with beta-amyloid deposition in the cognitively normal elderly Snitz, Beth
2013
9 4S p. P780
artikel
1859 Subjective cognitive concerns, amyloid burden and cognitive reserve Mormino, Elizabeth
2013
9 4S p. P133-P134
artikel
1860 Subjective cognitive concerns as an early indicator of Alzheimer’s disease pathology Amariglio, Rebecca
2013
9 4S p. P824-P825
artikel
1861 Subjective experiences following a diagnosis of Alzheimer's disease Valgardsdottir, Arndis
2013
9 4S p. P745
artikel
1862 Subjectively assessed performance on activities of daily living only partly captures objectively assessed gait dysfunction Verlinden, Vincentius
2013
9 4S p. P619
artikel
1863 Subjective memory concerns, objective memory impairment and risk of Alzheimer's dementia in people with MCI Wolfsgruber, Steffen
2013
9 4S p. P761-P762
artikel
1864 Subjective memory impairment in healthy elderly specifically predicts decline in episodic memory over 8 years Koppara, Alexander
2013
9 4S p. P782
artikel
1865 Subjective memory symptoms, verbal memory decline and the APOE-ε4 allele Samieri, Cécilia
2013
9 4S p. P778-P779
artikel
1866 Subscriber information 2013
9 4S p. A8
artikel
1867 Superficial siderosis with predominant frontal lobe deposition in a person with Lewy body dementia Bruns, Marla
2013
9 4S p. P389
artikel
1868 Sustained cognitive benefit in patients with mild cognitive impairment (MCI) upon prolonged treatment with CHF5074 Ross, Joel
2013
9 4S p. P530
artikel
1869 SUVN-512: A novel 5-HT6 receptor antagonist with drug-like properties Babu, Medapati Rajesh
2013
9 4S p. P816
artikel
1870 SUVN-D1208045, a potent selective 5-HT4 receptor partial agonist for the treatment of Alzheimer's disease Nirogi, Ramakrishna
2013
9 4S p. P817
artikel
1871 Symptoms of androgen deficiency in Chinese older men with mild cognitive impairment Chu, Leung-wing
2013
9 4S p. P766
artikel
1872 Synergistic inhibition of synaptic signaling in cortical cultures by subcytotoxic levels of iron and exogenously applied oligomerized beta-amyloid Taddeo, Marta
2013
9 4S p. P876
artikel
1873 Synthetic beta-amyloid prions Stoehr, Jan
2013
9 4S p. P168
artikel
1874 Systematic evaluation of candidate ligands regulating ectodomain shedding of the amyloid precursor protein Rice, Heather
2013
9 4S p. P183
artikel
1875 Systemic administration of insulin-like growth factor 2 results in increased BOLD pharmacological MRI response in memory-related brain regions Shamy, Jul Lea
2013
9 4S p. P159-P160
artikel
1876 Systemic inflammation and brain white matter in non-demented elderly human subjects: A diffusion tensor magnetic resonance imaging investigation Grisot, Giorgia
2013
9 4S p. P700-P701
artikel
1877 Systemic inflammatory responses to stress and its impact on cognition in people with mild cognitive impairment Sussams, Rebecca
2013
9 4S p. P775
artikel
1878 Systems medicine: A new model for dementia research? Llewellyn, David
2013
9 4S p. P884
artikel
1879 Systolic blood pressure and double product are associated with reduced hippocampal volume in the Alzheimer's Disease Neuroimaging (ADNI) study Iyalomhe, Osi
2013
9 4S p. P627-P628
artikel
1880 Tacrolimus attenuates intracerebroventricular streptozotocin-induced cognitive dysfunction and oxidative stress Kumar, Kushal
2013
9 4S p. P817
artikel
1881 Talking about the past and the future: A characterization of responses to questions about personal past and future plans in treated and untreated people with Alzheimer's disease Asp, Elissa
2013
9 4S p. P758
artikel
1882 Targeted lipidomic pathway-guided genetic association with Alzheimer's disease–relevant endophenotypes Kim, Sungeun
2013
9 4S p. P680-P681
artikel
1883 Targeted lipidomic-pathway–guided genetic association with Alzheimer's disease–relevant endophenotypes Kim, Sungeun
2013
9 4S p. P85-P86
artikel
1884 Targeting Alzheimer's disease–related mechanisms with p75 ligands Longo, Frank
2013
9 4S p. P674
artikel
1885 Targeting beta-secretase Vassar, Robert
2013
9 4S p. P677
artikel
1886 Targeting kinases hyperphosphorylating tau protein: Elucidation of kinase inhibition profile most efficient in restoring physiological tau phosphorylation Nowak, Mateusz
2013
9 4S p. P891
artikel
1887 Targeting protein-protein interactions in heat shock protein 70 (Hsp70) to treat neurodegenerative disease Gestwicki, Jason
2013
9 4S p. P512
artikel
1888 Task-free fMRI in clinical trials: Selection of covariates and numeric endpoints Schwarz, Adam
2013
9 4S p. P588
artikel
1889 Task-free fMRI in clinical trials: Selection of covariates and numeric endpoints Schwarz, Adam
2013
9 4S p. P10
artikel
1890 Tau accumulation activates the unfolded protein response by impairing endoplasmic reticulum-associated degradation Abisambra, Jose
2013
9 4S p. P329-P330
artikel
1891 Tau as a prion: Mechanisms and implications Diamond, Marc
2013
9 4S p. P673
artikel
1892 Tau-based therapeutics for alzheimer's disease and related tauopathies Hutton, Michael
2013
9 4S p. P314
artikel
1893 Tau immunotherapy: The way to crack the immune code of misfolded protein tau Novak, Michal
2013
9 4S p. P674
artikel
1894 Tau levels, sleep-disordered breathing and BMI: A potential obesity paradox in Alzheimer's risk for people with sleep-disordered breathing Gumb, Tyler
2013
9 4S p. P222
artikel
1895 Tau oligomers and annular protofibrils in progressive supranuclear palsy Gerson, Julia
2013
9 4S p. P854-P855
artikel
1896 Tau oligomers in CSF: A novel biomarker for the diagnosis and evaluation of treatment for Alzheimer's disease and tauopathies Sengupta, Urmi
2013
9 4S p. P862-P863
artikel
1897 Tau pathology in the parahippocampal region is related to delusion in the elderly: Neuropathological study of two autopsy cases Arai, Tetsuaki
2013
9 4S p. P440
artikel
1898 Tau release from hTau mouse primary neuronal cultures d'Abramo, Cristina
2013
9 4S p. P714
artikel
1899 TBD 2013
9 4S p. P126
artikel
1900 TDP-43 and mixed pathologies in normal cognition, mild cognitive impairment and dementia James, Bryan
2013
9 4S p. P334
artikel
1901 TDP-43 pathology: A central brain pathology in age-related cognitive decline Schneider, Julie
2013
9 4S p. P437-P438
artikel
1902 Teaching children about dementia: Pilot findings from the hip hop old S.C.H.O.O.L. (Seniors Can Have Optimal aging and Ongoing Longevity) program Noble, James
2013
9 4S p. P341
artikel
1903 Temporal dynamics of imaging biomarkers in predementia stages of Alzheimer's disease Kljajevic, Vanja
2013
9 4S p. P590-P591
artikel
1904 Temporal evolution of biomarkers and cognitive markers from preclinical to clinical Alzheimer's disease: An Alzheimer's Disease Neuroimaging Initiative (ADNI) study Bertens, Daniela
2013
9 4S p. P523
artikel
1905 Temporoparietal cortical thickness outperforms hippocampal volume as a biomarker for atypical and early-onset Alzheimer's disease Cohn-Sheehy, Brendan
2013
9 4S p. P41-P42
artikel
1906 Temporoparietal cortical thickness outperforms hippocampal volume as a biomarker for atypical and early-onset Alzheimer's disease Cohn-Sheehy, Brendan
2013
9 4S p. P333
artikel
1907 Tendencies of treatment among people with Alzheimer's disease in Mexico: Findings from the National Dementia Survey—Study from the Mexican group of specialists in dementias Diaz, Santiago Ramirez
2013
9 4S p. P467-P469
artikel
1908 Ten ways meditation may prevent cognitive decline: A research summary Khalsa, Dharma
2013
9 4S p. P651
artikel
1909 Ten-year MRI changes and FBB-PET: Results from the Women's Healthy Aging Project (WHAP) Yates, Paul
2013
9 4S p. P401
artikel
1910 Testing the use of standardized scripts for disclosing ‘hypothetical/mock’ amyloid PET scan results to nondemented cognitively impaired patients and their care partners Witte, Michael
2013
9 4S p. P131-P132
artikel
1911 Test of executive functioning in an emergency (TEFE) Wiechmann, April
2013
9 4S p. P461
artikel
1912 Test-retest reliability of task fMRI across three sessions in people with mild cognitive impairment Pa, Judy
2013
9 4S p. P591-P592
artikel
1913 Test-retest reproducibility of brain morphometry, diffusion and resting-state fMRI: A 3T consortium study Jovicich, Jorge
2013
9 4S p. P598-P599
artikel
1914 Test-retest reproducibility of brain morphometry, diffusion and resting-state fMRI: A 3T consortium study Jovicich, Jorge
2013
9 4S p. P31-P32
artikel
1915 Test Your Memory Spanish version (TYM-S): Validation of a self-administered cognitive screening test Slachevsky, Andrea
2013
9 4S p. P458-P459
artikel
1916 Texture analysis of white matter hyperintensities for nondemented elders is related to visual and verbal episodic memory performance Damon, Stephen
2013
9 4S p. P602
artikel
1917 Tg4-42: A new mouse model of Alzheimer's disease—N-truncated amyloid β (Aβ) 4-42 induces severe neuron loss and behavioral deficits Bouter, Yvonne
2013
9 4S p. P498-P499
artikel
1918 Tg4-42: A new mouse model of Alzheimer's disease—N-truncated beta-amyloid 4-42 affects memory decline and synaptic plasticity Dietrich, Katharina
2013
9 4S p. P498
artikel
1919 Thalamic shape and cognitive performance in amnestic mild cognitive impairment Lee, Chang Uk
2013
9 4S p. P580
artikel
1920 The Addenbrooke's Cognitive Examination-Revised (ACE-R) battery in the diagnoses of mild cognitive impairment, Alzheimer's disease and frontotemporal dementia Carvalho, Viviane
2013
9 4S p. P462
artikel
1921 The Alzheimer's Disease Progression Score (ADPS) can predict the transition from MCI to Alzheimer's disease Jedynak, Bruno
2013
9 4S p. P223
artikel
1922 The amyloid precursor protein regulates brain lipid homeostasis Castello, Michael
2013
9 4S p. P188-P189
artikel
1923 The antioligomer effects of the metal-protein attenuating compound clioquinol Ryan, Timothy
2013
9 4S p. P363
artikel
1924 The arts and dementia: Personal identity and self-expression Caulfield, Sean
2013
9 4S p. P650
artikel
1925 The association between cardiovascular risk and neurocognitive measures of executive function in at-risk, community-dwelling older adults: An fMRI study Chuang, Yi-Fang
2013
9 4S p. P397
artikel
1926 The association between diabetes and dementia/Alzheimer's disease is modified by age: The Kame Project Borenstein, Amy
2013
9 4S p. P616
artikel
1927 The association of hand grip strength, skeletal muscle mass, 5-meter walking speed and bone mineral densitometry in a small population of Turkish elderly Safer, Umut
2013
9 4S p. P781
artikel
1928 The Audio Recorded Cognitive Screen: Outpatient reports on the experience of being tested Schofield, Peter
2013
9 4S p. P463-P464
artikel
1929 The beta-amyloid aggregate count in CSF is a biomarker for Alzheimer's disease Willbold, Dieter
2013
9 4S p. P128
artikel
1930 The beta-amyloid–heme model: Early neurotoxicity in Alzheimer's disease Atamna, Hani
2013
9 4S p. P853
artikel
1931 The binding of beta-amyloid 42 to lipid rafts containing detergent-resistant membranes of RBC ghost is enhanced by dietary docosahexaenoic acid in rats: An implication of erythrocyte functions to Alzheimer's disease Hashimoto, Michio
2013
9 4S p. P189
artikel
1932 The biomarkers of dementia severity vary widely by ethnicity: A latent variable approach Royall, Donald
2013
9 4S p. P727
artikel
1933 The Body, Brain, Life program: Baseline characteristics of an online multi-domain intervention to reduce the risk of Alzheimer's disease Bahar-Fuchs, Alex
2013
9 4S p. P651-P652
artikel
1934 The brain aging: Between beta-amyloid oligomers and individual variability of Alzheimer's disease-type lesions Bouras, Constantin
2013
9 4S p. P442
artikel
1935 The Centiloid Scale: Standardization of amyloid imaging measures Rowe, Christopher
2013
9 4S p. P8
artikel
1936 The changing face of the memory clinic in Sheffield, United Kingdom Blackburn, Daniel
2013
9 4S p. P493
artikel
1937 The classification of nondemented people attending a memory clinic according to the NIA and Alzheimer's Association guidelines on Alzheimer's disease-related biomarkers Ivanoiu, Adrian
2013
9 4S p. P414
artikel
1938 The clinical utility of blood-based biomarkers in Alzheimer's disease Soares, Holly
2013
9 4S p. P676
artikel
1939 The cocktail party effect in Alzheimer's disease Golden, Hannah
2013
9 4S p. P524-P525
artikel
1940 The cognitive process approach in assessment of visual perceptual functions can differentiate between Alzheimer's dementia and dementia with Lewy bodies Kramberger, Milica G.
2013
9 4S p. P792
artikel
1941 The comparison of cognitive profiles and gray matter densities between MCI and normal cognition in de novo PD Kim, Sang Jin
2013
9 4S p. P875
artikel
1942 The comparison of oligomeric beta-amyloid and total beta-amyloid in people with Alzheimer's disease and cognitively normal individuals A. An, Seong Soo
2013
9 4S p. P241
artikel
1943 The compliance of Reminyl of patients with Alzheimer's disease in Taiwan Lin, Ting Yang
2013
9 4S p. P891
artikel
1944 The correlation between vascular risk factors and Alzheimer's disease Zeng, Fan
2013
9 4S p. P740
artikel
1945 The ‘CSF Alzheimer’s profile’: Easily said, but what do we mean? Duits, Flora
2013
9 4S p. P147
artikel
1946 The differential impact of diabetes medications on cognition Lane, Elizabeth
2013
9 4S p. P206
artikel
1947 The dynamic changing of occipital dementia and posterior cortical atrophy Liu, Canyan
2013
9 4S p. P748-P749
artikel
1948 The effectiveness of a multidivisional cognitive program in preventing cognitive decline at a regional center for dementia Kim, Hee-Jin
2013
9 4S p. P654-P655
artikel
1949 The effectiveness of VSRAD in differentiating between mood disorder and ALZHEIMER'S disease Akahane, Akihisa
2013
9 4S p. P739-P740
artikel
1950 The effect of acute administration of levetiracetam on cerebral perfusion in Alzheimer's disease as measured by arterial spin labeling MRI Press, Daniel
2013
9 4S p. P894
artikel
1951 The effect of age and amyloid status on hippocampal atrophy rate in normal controls and people with mild cognitive impairment in the ADNI cohort Nosheny, Rachel
2013
9 4S p. P207
artikel
1952 The effect of age of starting a contact sport on subsequent brain volumes Simmons, Sierra
2013
9 4S p. P838-P839
artikel
1953 The effect of anticoagulant and sample preparation method on beta-amyloid oligomer detection in blood Kim, SangYun
2013
9 4S p. P241-P242
artikel
1954 The effect of APP mutations on BACE1 cleavage and APP processing Zhang, Shuting
2013
9 4S p. P182
artikel
1955 The effect of cognitive stimulation on cognition in the elderly Apostolo, Joao
2013
9 4S p. P650-P651
artikel
1956 The effect of education and literacy on performance on the Montreal Cognitive Assessment among cognitively normal elderly Julayanont, Parunyou
2013
9 4S p. P793
artikel
1957 The effect of intranasal rapid-acting insulin on APOE-ε4 carriers with mild-to-moderate Alzheimer's disease Rosenbloom, Michael
2013
9 4S p. P888
artikel
1958 The effect of melatonin on lifespan in the model organism Caenorhabditis elegans Karadas, Omer
2013
9 4S p. P162
artikel
1959 The effect of morphine on water maze memory consolidation Khales, Golnaz Yadollahi
2013
9 4S p. P154
artikel
1960 The effect of okadaic acid–induced tau hyperphosphorylation on Pin1 expression in primary cortical neurons Metin, Derya
2013
9 4S p. P715
artikel
1961 The effect of prophylactic melatonin usage on cognitive functions in a case of Alzheimer's disease Gul, Hakan
2013
9 4S p. P303
artikel
1962 The effect of rapid cognitive decline in MCI and Alzheimer's disease on level of dependence, resource utilization, carer satisfaction, burden and attitudes to aging Copolov, Carly
2013
9 4S p. P487-P488
artikel
1963 The effect of repetitive mild traumatic brain injury on the pathologies of Alzheimer's disease Stein, Thor
2013
9 4S p. P187
artikel
1964 The effect of TOMM40 on spatial navigation in amnestic mild cognitive impairment Laczó, Jan
2013
9 4S p. P464
artikel
1965 The effect of topiramate usage on cognitive functions in a case of Alzheimer's disease Gul, Hakan
2013
9 4S p. P302-P303
artikel
1966 The effect of using a conditional discrimination procedure to teach name-face relation to a person diagnosed with dementia Steingrimsdottir, Hanna S.
2013
9 4S p. P760-P761
artikel
1967 The effect of vascular risk factors on the rate of cognitive change in older adults: Data from the Australian Imaging Biomarkers and Lifestyle (AIBL) flagship study Restrepo, Carolina
2013
9 4S p. P454-P455
artikel
1968 The effects of aging on whole-brain functional connectivity Brier, Matthew
2013
9 4S p. P394
artikel
1969 The effects of aging on whole-brain functional connectivity Brier, Matthew
2013
9 4S p. P7
artikel
1970 The effects of cerebral small-vessel disease in normal-appearing white matter integrity in mild cognitive impairment: A diffusion tensor imaging study Papma, Janne
2013
9 4S p. P96-P97
artikel
1971 The effects of cerebral small vessel disease in normal appearing white matter integrity in mild cognitive impairment: A diffusion tensor imaging study Papma, Janne
2013
9 4S p. P835-P836
artikel
1972 The effects of cognitive reserve and apolipoprotein E on healthy cognitive function Ward, David
2013
9 4S p. P559
artikel
1973 The effects of exercise on memory performance in older adults with probable mild cognitive impairment: A 6-month randomized controlled trial Nagamatsu, Lindsay
2013
9 4S p. P293-P294
artikel
1974 The effects of gene mutations on the cerebrospinal fluid levels of soluble amyloid precursor proteins in familial Alzheimer's disease Thordardottir, Steinunn
2013
9 4S p. P226-P227
artikel
1975 The effects of group cognitive-rehabilitation therapy on the elderly with mild cognitive impairment in the Gangdong Seniors Welfare Service Center Yeon, Byeong Kil
2013
9 4S p. P647
artikel
1976 The effects of tau hyperphosphorylation on the release of brain-derived neurotrophic factor in primary cortical neuron cultures Atasoy, Irem Lutfiye
2013
9 4S p. P714-P715
artikel
1977 The efficacy of anti-beta-amyloid oligomers antibody in mouse models of Alzheimer's disease Okamoto, Yasuhide
2013
9 4S p. P502
artikel
1978 The efficacy of the General Practitioners Assessment of Cognition (GPCOG) for a Brazilian population in a primary care context: Preliminary results Yokomizo, Juliana
2013
9 4S p. P451
artikel
1979 The exosomal transcytosis mechanism of tau dissemination through neuron-microglia interaction Asai, Hirohide
2013
9 4S p. P713
artikel
1980 The first autopsy report from J-ADNI Furukawa, Katsutoshi
2013
9 4S p. P434
artikel
1981 The first blood-based biomarker of Alzheimer's disease with high predictability: Oligomeric beta-amyloid detection by multimer detection system Kim, SangYun
2013
9 4S p. P848
artikel
1982 The front lines: A non-pharmacological approach to neuropsychiatric symptoms and problem behaviors in dementia Kales, Helen
2013
9 4S p. P2
artikel
1983 The genetic basis of episodic memory performance in the elderly: Is there a link to micro-RNAs? Schröder, Julia
2013
9 4S p. P558-P559
artikel
1984 The genetics of lipid metabolism in Alzheimer's disease susceptibility Jones, Lesley
2013
9 4S p. P121
artikel
1985 The Hsp90 co-chaperone FKBP51 produces neurotoxic tau oligomers: Implication for aging and Alzheimer's disease Blair, Laura
2013
9 4S p. P173
artikel
1986 The 5-HT6 antagonist Lu AE58054 potentiates the effects of the acetylcholinesterase inhibitor donepezil on hippocampal extracellular acetylcholine efflux and oscillatory activity Herrik, Kjartan Frisch
2013
9 4S p. P503
artikel
1987 The identification of rare variants in late-onset Alzheimer’s disease using extended families Kohli, Martin
2013
9 4S p. P518-P519
artikel
1988 The impact of beta-amyloid deposition and vascular risk factors on cortical thickness and cognition Villeneuve, Sylvia
2013
9 4S p. P21-P22
artikel
1989 The impact of beta-amyloid deposition and vascular risk factors on cortical thickness and cognition Villeneuve, Sylvia
2013
9 4S p. P274-P275
artikel
1990 The impact of carotid artery stenting on cognitive profiles in people with severe carotid artery stenosis: A prospective, case-control, follow-up study Park, Kyung Won
2013
9 4S p. P671
artikel
1991 The impact of gradient field distortion on the calculation of brain atrophy in Alzheimer's disease, derived from volumetric MRI using the boundary shift integral Einstein, Steven
2013
9 4S p. P105
artikel
1992 The impact of gradient field distortion on the calculation of brain atrophy in Alzheimer's disease, derived from volumetric MRI using the boundary shift integral Einstein, Steven
2013
9 4S p. P281
artikel
1993 The impact of 2y B-vitamin supplementation on cognitive performance: The B-PROOF study van der Zwaluw, Nikita
2013
9 4S p. P880-P881
artikel
1994 The importance of family and caregiver in the care and management of people with Alzheimer's disease Galvin, James
2013
9 4S p. P1-P2
artikel
1995 The incidence and recurrence of getting lost in people with Alzheimer's disease: A 2.5-year follow-up Pai, Ming-Chyi
2013
9 4S p. P743-P744
artikel
1996 The increased susceptibility to oxidative death of lymphocytes from people with Alzheimer's disease correlates with the severity of dementia and is specific for oxidative damage Ponce, Daniela P
2013
9 4S p. P566-P567
artikel
1997 The increase of BRI2 in early stages of Alzheimer's disease correlates with reduced levels of ADAM10 and may prevent its binding to APP Del Campo Milan, Marta
2013
9 4S p. P574
artikel
1998 The influence of genetic variants in SORL1 gene on the manifestation of Alzheimer's disease Louwersheimer, Eva
2013
9 4S p. P173-P174
artikel
1999 The influence of mild cognitive impairment on measures of fall risk in community-dwelling older adults Blackwood, Jennifer
2013
9 4S p. P864
artikel
2000 The influence of planning efficiency in the Tower of London visioconstruction test in the elderly de Paula, Jonas
2013
9 4S p. P460
artikel
                             2253 gevonden resultaten
 
<< vorige    volgende >>
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland